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ABSTRACT 
  
Vitamin D has predominantly been associated with calcium homeostasis, but recently 
been associated with several infectious diseases.  The active vitamin D metabolite, 1,25-
dihydroxyvitamin D3 (1,25(OH)2D3), is known to regulate the expression of numerous genes 
throughout the body. 1,25(OH)2D3 is synthesized from 25-hydroxyvitamin D3 by the enzyme 
1α-hydroxylase (1α-OHase; CYP27B1). In the endocrine system, 1α-OHase expression, and 
subsequently 1,25(OH)2D3 synthesis, is tightly regulated in the kidney in response to calcium 
homeostasis.  1,25(OH)2D3 produced in the kidney acts systemically to regulate the 
expression of genes related to calcium homeostasis.  In contrast, we have found that bovine 
monocytes (precursors to macrophages) express 1α-OHase upon activation by toll-like 
receptor recognition of pathogen associated molecular patterns.  Furthermore, we found that 
1α-OHase is highly expressed in CD14+ cells (monocytes and macrophages) from peripheral 
blood mononuclear cell cultures stimulated with a purified protein derivative of 
Mycobacteria bovis and from the infected mammary glands of cows with mastitis.  
Production of 1,25(OH)2D3 by 1α-OHase in bovine monocytes up-regulated the expression 
of the genes for iNOS and the chemokine RANTES in monocytes.  Up-regulation of iNOS 
resulted in increased production of nitric oxide, a molecule that is considered to have several 
important roles in immune function.  In stimulated peripheral blood mononuclear cell 
cultures, IFN-γ, IL-17A, and IL-17F, pro-inflammatory cytokines associated with T-cells, 
were down-regulated by 1,25(OH)2D3 that was presumably produced by monocytes.  Finally, 
regulation of gene expression by 1,25(OH)2D3 produced by 1α-OHase in monocytes 
depended on the concentration of 25(OH)D3.  The circulating concentration of 25(OH)D3 is 
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controlled by dietary intake of vitamin D3 and sunlight exposure, so dietary intake of vitamin 
D3 and sunlight exposure may impact immune function in cattle.  Current requirements for 
vitamin D in cattle are based on the regulation of calcium homeostasis, but those 
requirements may be inadequate for proper immune function.  Therefore, further 
investigation is needed to determine vitamin D requirements for proper immune function in 
cattle.  
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CHAPTER 1. GENERAL INTRODUCTION 
 
Introduction 
 Vitamin D historically has been associated with calcium homeostasis (Horst et al., 
2003).  In recent years, though, vitamin D has gained popularity for the role it has in the 
immune system (Adams et al., 2007b; DeLuca, 2008). A noteworthy discovery was made by 
several groups in 2004 and 2005 that 1,25(OH)2D3 up-regulated the expression of 
cathelicidin in human macrophages and enhance the antimicrobial activity of macrophages 
(Gombart et al., 2005; Wang et al., 2004).  Shortly after, Liu et. Al. showed that human 
macrophages expressed 1α-hydroxylase (1α-Ohase) upon activation by toll-like receptor 
signaling (Liu et al., 2006).  Enzymatic activity of 1α-OHase converts 25-hydroxyvitamin D3 
to 1,25(OH)2D3.  In activated human macrophages, production of 1,25(OH)2D3 by 1α-OHase 
enhanced cathelicidin expression and antimicrobial activity (Liu et al., 2006).  These 
discoveries led to the concept that vitamin D signaling in the immune system functions 
through intracrine and paracrine mechanisms (Hewison, 2010).   
Studies with humans and mice suggest that over 1,000 genes may be regulated by 
1,25(OH)2D3 and that 1,25(OH)2D3 regulates numerous immune responses (Wang et al., 
2005).  Yet, in bovine immune cells, 1,25(OH)2D3 is only known to repress interferon-γ 
production and enhance nitric oxide production.  So, one objective of this dissertation project 
was to identify genes with immunological function that are regulated by 1,25(OH)2D3 in 
cattle.  Meanwhile, the kidney has been the only known source for 1,25(OH)2D3 in cattle, but 
evidence from humans and mice suggests that immune cells also synthesize 1,25(OH)2D3 
(Stoffels et al., 2007; Stoffels et al., 2006).  Therefore, another objective of this dissertation 
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project was to find if extra-renal production of 1,25(OH)2D3  occurs to regulate immune 
responses through intracrine and paracrine mechanisms.     
The information gained from this project could lead to a better understanding of 
factors that affect host defense mechanisms in cattle.  Bacterial and viral diseases of cattle 
result in major economic losses and threaten food safety and supply.  As a result, identifying 
the mechanisms and effects of vitamin D signaling in the bovine immune system may have 
substantial implications for livestock production. 
 
Dissertation Organization 
 This dissertation contains five chapters and two appendices.  A review of the 
literature on vitamin D and immunology is given in chapter 1.  Chapter 2 has been published 
in the Journal of Dairy Science (Nelson et al., 2010).  That paper consists of several in vitro 
experiments that show production of 1,25(OH)2D3 by 1α-OHase in bovine monocytes 
regulates expression of the genes for iNOS and RANTES in monocytes.  Chapter 3 is a 
manuscript describing research that gives evidence that 1α-OHase is expressed only by CD14 
positive cells (monocytes/macrophages) in peripheral blood mononuclear cell cultures 
stimulated with a purified protein derivative of Mycobacteria bovis.  That manuscript also 
gives evidence that production of 1,25(OH)2D3 by monocytes can regulate gene expression in 
surrounding cells.  Chapter 4 is a manuscript describing research that provides in vivo 
evidence that 1α-OHase is expressed by macrophages in the mammary gland during mastitis.  
Chapter 5 is a general conclusion and contains ideas for future research.  References for each 
chapter can be found after the chapter in which they appear.  Appendix A contains un-
published results on the effects of 25(OH)D3 and 1,25(OH)2D3 on monocyte anti-bacterial 
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activity.  Appendix B contains preliminary results on 1α-OHase gene expression in bovine 
mammary epithelial cells and the effects of 1,25(OH)2D3 on gene expression in bovine 
mammary epithelial cells.  
   
Literature Review 
 
History of vitamin D research  
In the 19th century, sunlight exposure was prescribed as a cure for rickets and 
tuberculosis (McCarthy, 2001; Rajakumar, 2003).  Nearly a century ago, vitamin D was 
discovered as the factor in butterfat and cod liver oil that prevented rickets (McCollum et al., 
2002).  A few years later, vitamin D was found to be synthesized in skin exposed to sunlight; 
which explained why sunlight exposure could cure rickets.  However, why sunlight exposure 
cured tuberculosis was not clear until recently (Liu et al., 2006).  Here is an overview of the 
events that led to the discovery of vitamin D and the physiological roles the vitamin has in 
both diseases. 
 The study of rickets ultimately led to the discovery of vitamin D.  In 1914, E.V. 
McCollum and E.B. Hart found that a fat-soluble factor in butterfat was necessary for normal 
growth in rats (Rajakumar, 2003).  Soon after, Edward Mellanby discovered that a fat-soluble 
factor in butterfat or cod liver oil could prevent rickets (Carpenter and Zhao, 1999).  In 1922, 
McCollum described a “fourth vitamin” that, as far as he could tell, “regulated the 
metabolism of bones” (McCollum et al., 2002).  The process of irradiating food with UV 
light was patented by Harry Steenbock in 1924 because he found that irradiated food could 
prevent rickets (Steenbock, 1924).  In 1925, A. F. Hess suggested that UV light activated 
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cholesterol in the skin to make it anti-rachitic (Wolf, 2004).  In the early 1930s, Windaus and 
Rosenheim discovered that UV irradiation of ergosterol from plants produced vitamin D2 
(Wolf, 2004).  Windaus finally discovered that cholecalciferol (vitamin D3) was derived from 
7-dehydrocholesterol in the skin by UV irradiation in 1937 (Wolf, 2004).  Discovering that 
vitamin D3 was synthesized in skin exposed to UV light explained earlier observations that 
exposure to UV light could prevent rickets.     
After discovery of vitamin D, research efforts focused on how it regulated calcium 
homeostasis.  In the late 1960s, Hector Deluca found that vitamin D3 was converted rapidly 
to 25-hydroxyvitamin D3 (DeLuca, 1969).  Soon after, several groups showed that 25(OH)D3 
was converted to 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3) and that 1,25(OH)2D3 was the 
active metabolite (DeLuca, 1976; Norman and Wong, 1972). Around that time, a receptor for 
1,25(OH)2D3, now known as the vitamin D receptor (VDR), was shown to associate with 
chromatin (Tsai et al., 1972). Identification of a receptor for 1,25(OH)2D3 that acted as a 
transcription factor provided an explanation for how vitamin D regulated calcium 
homeostasis.  Eventually, 1,25(OH)2D3 was found to be produced in the kidney by the 
enzyme 25-hydroxyvitamin D 1α-hydroxylase (1α-Ohase) (DeLuca, 1976).  Altogether, 
these discoveries led to the concept of the vitamin D endocrine system, where 1,25(OH)2D3 
production was regulated in the kidney to control the circulating concentration of 
1,25(OH)2D3 and 1,25(OH)2D3 acts as a hormone to regulate gene expression systemically 
(DeLuca, 1980; Horst and Reinhardt, 1983).   
 Evidence slowly emerged that vitamin D contributed to immune function in the early 
1980s.  The VDR was shown to be expressed in immune cells (Provvedini et al., 1983).  
Several studies showed that 1,25(OH)2D3 affected immune cell proliferation and 
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differentiation (Koeffler et al., 1984; Lemire et al., 1984; Mangelsdorf et al., 1984).  In 1983, 
pulmonary macrophages from sarcoidosis patients were shown to produce 1,25(OH)2D3 
(Adams et al., 1983).  Activation of macrophages with interferon gamma (IFN-γ) then was 
shown to induce production of 1,25(OH)2D3 (Koeffler et al., 1985).  In the 1990s, it was 
shown that 1,25(OH)2D3 could prevent disease onset in mouse models of autoimmune 
disorders (Cantorna et al., 1996, 1998a).  Also during that time, vitamin D deficiency was 
linked to the incidence of multiple sclerosis (Hayes et al., 1997).   
 In terms of host defense against infectious disease, two separate research groups 
showed that 1,25(OH)2D3 induced cathelicidin expression in human macrophages and 
epithelial cells (Gombart et al., 2005; Wang et al., 2004).  This discovery became even more 
prominent a few years later when Liu and co-workers showed that toll-like receptor (TLR) 
signaling induced 1,25(OH)2D3 production by 1α-OHase in macrophages (Liu et al., 2006).  
Production of 1,25(OH)2D3 up-regulated the expression of cathelicidin and subsequently 
killing of intracellular Mycobacteria tuberculosis (Liu et al., 2007b).  Even though 
production of 1,25(OH)2D3 in macrophages had been shown two decades earlier, this 
discovery was the first time a solid link between vitamin D and host defense was made.  That 
discovery provided some explanation for the 19th century observation that sunlight exposure 
could cure tuberculosis.   
 In cattle, most of the information on vitamin D in cattle relates to its role in calcium 
homeostasis.  A major metabolic disease in dairy cattle is milk fever, or severe 
hypocalcemia; so, a great deal of effort from the 1970s until recently was spent 
understanding the role of vitamin D in this disease (Horst, 1986; Horst et al., 1997; Horst and 
Reinhardt, 1983).  Those efforts have provided information on the vitamin D endocrine 
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system and vitamin D requirements for proper calcium homeostasis.  Several studies have 
shown 1,25(OH)2D3 regulates immune function in cattle (Ametaj et al., 1996; Nonnecke et 
al., 2003; Reinhardt et al., 1999; Waters et al., 2001), but knowledge about vitamin D 
signaling in the bovine immune system lags behind what is known about vitamin D signaling 
in the human immune system.    
 
Vitamin D metabolism 
 Vitamin D2 and vitamin D3 metabolites are found in plasma of cattle (Sommerfeldt et 
al., 1983).  Vitamin D2 is derived from ergosterol in plants and vitamin D3 is derived from 7-
dehydrochlesterol in animals (Figure 1).  In cattle, vitamin D2 and vitamin D3 metabolism 
occurs through the same pathway, with exceptions in digestion in the rumen and side chain 
catabolism (Horst et al., 1990; Horst and Littledike, 1979; Zimmerman et al., 2001).  Even 
though both forms contribute to the overall signaling events of vitamin D, vitamin D3 is the 
predominant form in cattle because it is synthesized in the skin and supplemented in the diet 
(Horst et al., 1981).   Therefore, the focus of this review will be on vitamin D3.  The 
metabolic pathway of vitamin D3 is shown in Figure 1. 
Vitamin D3 is synthesized in the skin from 7-dehydrocholesterol by irradiation with 
UVB light (Holick, 2008).  Vitamin D3 also can be acquired in the diet (McDermott et al., 
1985).  The NRC recommendation of vitamin D3 intake for lactating dairy cows is about 
20,000 international units (IU; 25 ng = 1 IU) per day depending on animal size and milk 
production (NRC, 2001).  The recommendation for calves is 600 IU/day (NRC, 2001).  Many 
dairy operations, however, have supplemented the diets of lactating cattle with about 40,000 
IU/day and most calf milk replacers provide about 10,000 IU/day (Weiss, 1998).    
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 Vitamin D3 is converted to 25(OH)D3 in the liver by several cytochrome P450 
enzymes (Dusso et al., 2005).  CYP27A1 is recognized most often as the enzyme that 
converts vitamin D3 to 25(OH)D3, but  CYP2C11, CYP2R1, and CYP3A4 also have been 
shown to catalyze the conversion (Dusso et al., 2005).  Conversion of vitamin D3 to 
25(OH)D3 is not tightly regulated; so, most vitamin D3 that is acquired in the diet or 
synthesized in the skin is quickly converted to 25(OH)D3 (Horst et al., 1994).  25(OH)D3 is 
the most abundant vitamin D metabolite in plasma of cattle (Horst et al., 1981). 
The concentration of 25(OH)D3 in plasma is relatively stable over time (Sommerfeldt 
et al., 1983).  It does not change in response to calcium homeostasis or health status, but 
depends on dietary intake and sunlight exposure (Horst et al., 1997; Waldron et al., 2003).  
As a result, the concentration of 25(OH)D3 is used as a measure of vitamin D status (Hollis et 
al., 2007).  In cattle, the concentration of 25(OH)D3 in plasma typically ranges from 20 to 50 
ng/ml (Horst et al., 1994).  Heavy supplementation of vitamin D3 (> 50,000 IU/day for 
lactating cow or 10,000 IU/day for calf) can result in plasma 25(OH)D3 concentrations 
ranging from 50 to 100 ng/ml (McDermott et al., 1985; Nonnecke et al., 2009).  Excess 
supplementation of vitamin D3 in the diet can cause calcification of soft tissues can occur 
when the plasma 25(OH)D3 concentration exceeds 200 ng/ml (Littledike and Horst, 1982).  
In the absence of dietary supplementation, the plasma 25(OH)D3 concentration depends on 
sun exposure and is subject to seasonal variation (Hymoller et al., 2009). 
25(OH)D3 is the precursor for the biologically active metabolite, 1,25(OH)2D3 (Horst 
et al., 1994). 25(OH)D3 is converted to 1,25(OH)2D3 by addition of a hydroxyl group in the 
1α position by cytochrome P450 enzyme CYP27B1 (Sakaki et al., 2005).  CYP27B1 also is 
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known as the 25-hydroxyvitamin D 1α-hydroxylase (1α-Ohase) and is the only known 
enzyme that converts 25(OH)D3 to 1,25(OH)2D3 (Panda et al., 2001).   
The circulating concentration of 1,25(OH)2D3 is regulated by the kidney in response 
to calcium homeostasis (Horst et al., 2003). The normal concentration of 1,25(OH)2D3 in 
plasma ranges from 5-20 pg/ml in cattle, but during severe hypocalcemia it may elevate to > 
300 pg/ml (Horst et al., 1994).  When the calcium concentration drops, parathyroid hormone 
(PTH) is released, which elevates 1α-OHase expression in kidney causing an increase in the 
circulating concentration of 1,25(OH)2D3 (Engstrom et al., 1987; Hove et al., 1984). 
1,25(OH)2D3 stimulates calcium absorption in the intestine and calcium reabsorption in 
bones and the kidney (Horst et al., 2003).  Extra-renal 1α-OHase expression does occur but is 
regulated in response to other stimuli and will be discussed later.  
Both 25(OH)D3 and 1,25(OH)2D3 are substrates for CYP24A1 (Engstrom et al., 
1984).  CYP24A1, or 24-hydroxylase (24-OHase), is another cytochrome P450 enzyme that 
adds a hydroxyl group at the 24 positions of both 25(OH)D3 and 1,25(OH)2D3 (Sakaki et al., 
2005).  The expression of 24-OHase increases with the concentration of 1,25(OH)2D3 
(Beckman et al., 1994; Reinhardt et al., 1989).  24-Hydroxyvitamin D3 metabolites are 
essentially inactive; so, the function of 24-OHase serves as a feedback regulator of 
1,25(OH)2D3 synthesis (Reinhardt and Horst, 1989).  24-hydroxyvitamin D3 metabolites 
undergo further side chain oxidation in the kidney to eventually form more polar metabolites, 
which are excreted in the bile (Horst et al., 1994). 
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Transport of vitamin D metabolites 
  Specialized mechanisms exist to transport vitamin D metabolites because they are 
hydrophobic compounds (Dusso et al., 2005).  Nearly all vitamin D metabolites in serum are 
bound by the vitamin D binding protein (DBP) (Brown et al., 1999).  DBP is a member of the 
albumin family of serum proteins and is produced in the liver (Haddad, 1995).  It has 
multiple functions besides vitamin D binding, including actin binding, macrophage 
activation, and fatty acid transport (Speeckaert et al., 2006).  DBP has the highest affinity for 
25(OH)D3, the major vitamin D metabolite in serum (Haddad et al., 1992).  The 
concentration of DBP in human serum is about 5 µM, which is over 100X greater than the 
concentration of 25(OH)D3 in serum (Brown et al., 1999).  As a result, over 99.9% of 
25(OH)D3 and 99% of 1,25(OH)2D3 in serum are bound by DBP (White and Cooke, 2000).  
Even still, only 5% of DBP in serum is occupied by vitamin D metabolites (Haddad, 1995).   
Transport of vitamin D metabolites in serum by DBP is an important process in 
vitamin D metabolism and signaling (Brown et al., 1999).  DBP extends the lifetime of 
25(OH)D3 in serum and allows for storage of 25(OH)D3 in plasma that is readily accessible 
(Cooke and Haddad, 1989).  The maintenance of free versus bound 1,25(OH)2D3 by DBP is 
another important role because free 1,25(OH)2D3 has greater access to target cells (Bikle and 
Gee, 1989).  In fact, vitamin D toxicity is thought to occur when DBP becomes saturated 
with 25(OH)D3 and 1,25(OH)2D3 is freed (Vieth, 2007). 
 Vitamin D metabolites not bound by the DBP will enter the cell by diffusion; 
however, facilitated uptake of 25(OH)D3 bound by DBP also occurs (Dusso et al., 2005).  
Megalin and cubulin, members of the low density lipoprotein receptor family, have been 
shown to facilitate endocytosis of DBP in kidney proximal tubule cells and mammary 
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epithelial cells (Nykjaer et al., 1999; Rowling et al., 2006).  Subsequently, synthesis of 
1,25(OH)2D3 in those cells depended on megalin-mediated endocytosis of DBP-bound 
25(OH)D3.  Upon endocytosis, DBP is degraded in the lysosome and the bound vitamin D 
metabolites are released (Adams et al., 2007a).  There are several intracellular DBPs (IDBP) 
that are known to transport vitamin D metabolites in the cell (Adams et al., 2007a).  The 
IDBPs are members of the inducible heat shock protein family (hsp-70) that seem to promote 
synthesis and action of 1,25(OH)2D3 by facilitating transport of 25(OH)D3 to the 
mitochondria and 1,25(OH)2D3 to the vitamin D receptor (VDR) (Adams et al., 2004).  
Therefore, intracellular transport of vitamin D metabolites also seems to be an important 
process in vitamin D metabolism and signaling.   
 
Genomic actions of 1,25(OH)2D3 
The biological function of 1,25(OH)2D3 is to regulate gene expression (Horst et al., 
2005). 1,25(OH)2D3 regulates gene expression by activating the vitamin D receptor (VDR) 
(Koszewski et al., 1996; Pike et al., 2007).  The VDR is a nuclear hormone receptor that has 
a ligand binding domain, a domain that forms a heterodimer with the retinoid X receptor 
(RXR), and a DNA binding domain (Dusso et al., 2005).  The ligand binding domain 
contains a ligand binding site with an affinity for 1,25(OH)2D3 (Kd = 100 pM) that is about 
100 times greater than the affinity for 25(OH)D3 (Reinhardt et al., 1989).  Binding of 
1,25(OH)2D3 to the VDR promotes heterodimerization of the VDR with the RXR and nuclear 
localization (Barsony and Prufer, 2002).  The DNA binding domains of the VDR/RXR 
heterodimer recognize DNA sequences, known as vitamin D response elements (VDREs), in 
the promoter regions of vitamin D responsive genes (Lin and White, 2004).  There are a few 
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different types of VDREs that are recognized by the VDR/RXR heterodimer, and the type of 
VDRE recognized by the VDR/RXR heterodimer depends on the orientation of the 
heterodimer (Lin and White, 2004).  The most common VDRE is known as a DR3, which is 
a direct repeat of PuG(G/T)TCA separated by 3 bases (Lin and White, 2004).  An inverted 
repeat of that sequence separated by nine bases is another VDRE that is recognized by the 
VDR/RXR heterodimer but is not as common (Lin and White, 2004). 
As mentioned earlier, 24-OHase expression increases with 1,25(OH)2D3 
concentration.  Analysis of the 24-OHase promoter in several species has revealed the 
presence on multiple VDREs, which explains why it is so responsive to 1,25(OH)2D3 in 
many different tissues (Vaisanen et al., 2005).  Besides 24-OHase, in silico analysis of the 
human and murine genomes has revealed that nearly 1,000 genes have promoters with 
potential VDREs (Wang et al., 2005).  Regulation of each gene would depend on the 
presence of the VDR and accessibility of the promoter, but the wide distribution of VDREs 
does suggest that 1,25(OH)2D3 has a multitude of effects throughout the body (Carlberg and 
Dunlop, 2006).   
 
Regulation of immune responses by 1,25(OH)2D3  
Initial evidence that 1,25(OH)2D3 acts in immune cells came from observations that 
1,25(OH)2D3 inhibited proliferation of lymphocytes and promoted differentiation of 
monocytes to macrophages (Koeffler et al., 1984; Lemire et al., 1984; Mangelsdorf et al., 
1984).  Recently, 1,25(OH)2D3 has been shown to enhance antimicrobial activity of human 
macrophages by directly up-regulating expression of the genes for cathelicidin antimicrobial 
peptide and defensin β4 (DEFB4) (Liu et al., 2009; Wang et al., 2004).  Subsequently, 
 12
cathelicidin-dependent killing of Mycobacterium tuberculosis in human macrophages has 
been shown (Liu et al., 2007b).  The promoter of the cathelicidin gene in humans contains a 
VDRE (Wang et al., 2004).  Cathelicidin gene expression is not regulated by 1,25(OH)2D3 in 
mice, however, and the presence of a VDRE in the cathelicidin promoter is primate specific 
(Gombart et al., 2009).  In regards to cattle, there are 11 cathelicidin genes and none of them 
are known to be regulated by 1,25(OH)2D3 (Zanetti, 2004).   
The effects of 1,25(OH)2D3 on innate immunity go beyond enhancement of 
antimicrobial peptide gene xpression. 1,25(OH)2D3 up-regulates CD14 and NOD2 gene 
expression in human monocytes (Liu et al., 2006; Wang et al., 2010).  Both of those genes 
are involved in recognition of pathogens.  In dendritic cells, 1,25(OH)2D3 enhanced CCL22, 
a chemokine that attracts regulatory T-cells, and CD300LF, an inhibitory cell surface 
receptor (Szeles et al., 2009).  Migration of myeloid dendritic cells to the lymph nodes 
increased in mice treated with 1,25(OH)2D3 (Enioutina et al., 2009).  In that study, migration 
of myeloid dendritic cells to lymph nodes was less in VDR knock out mice than in wild type 
mice.  
 In cattle, 1,25(OH)2D3 increases nitric oxide production by stimulated peripheral 
blood mononuclear cells (PBMCs) (Waters et al., 2001).  Nitric oxide is considered to have 
an antimicrobial and signaling role in the immune system (Bogdan, 2001).  Two studies have 
shown that 1,25(OH)2D3 increases inducible nitric oxide synthase (iNOS) expression in 
human monocytes (Martineau et al., 2007; Rockett et al., 1998).  In mouse monocytes, there 
is not evidence that nitric oxide production is increased by 1,25(OH)2D3, but M. tuberculosis 
killing depended on nitric oxide production (Thoma-Uszynski et al., 2001).  Furthermore, 
iNOS knockout mice developed more severe lesions than did wild type mice when infected 
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with M. tuberculosis (MacMicking et al., 1997; Waters et al., 2004).  Killing of M. 
tuberculosis by human monocytes, however, was not dependent on induction of iNOS 
expression (Thoma-Uszynski et al., 2001).  Instead, it seems to depend on induction of 
cathelicidin expression by 1,25(OH)2D3 (Liu et al., 2007b).   
 In addition to the effects 1,25(OH)2D3 has on innate immune functions, it also 
regulates adaptive immunity (Cantorna et al., 2004).  The general effects that 1,25(OH)2D3 
has on adaptive immunity are suppression of pro-inflammatory responses and enhancement 
of regulatory responses (Cantorna et al., 2008).  1,25(OH)2D3 inhibits onset of models of 
multiple sclerosis and inflammatory bowel disease in mice (Cantorna et al., 1996; Cantorna 
et al., 2000).  The exact mechanism 1,25(OH)2D3 has in preventing disease onset in each case 
is not entirely clear.  Activated T-cells, however, have a functional VDR, and studies with 
VDR knockout mice show the VDR is necessary for 1,25(OH)2D3-mediated inhibition of 
autoimmune disease (Froicu et al., 2003; Veldman et al., 2000).  
 In activated human PBMCs, IFN-γ production is down-regulated by 1,25(OH)2D3 
(Reichel et al., 1987).  IFN-γ is expressed by antigen-specific TH1-cells and functions as a 
macrophage activator (Hu and Ivashkiv, 2009). 1,25(OH)2D3 down regulated IFN-γ 
production in T-cell cultures that were activated with anti-CD3 (Baeke et al., 2010).  In a 
human T-cell line that over-expressed the VDR and a reporter gene under control of the IFN-
γ promoter, the VDR bound the IFN-γ promoter and repressed expression of the reporter 
gene (Cippitelli and Santoni, 1998). Several studies in cattle have shown that 1,25(OH)2D3 
represses antigen-specific IFN-γ responses to M. bovis in vitro (Ametaj et al., 1996; 
Nonnecke et al., 2003; Waters et al., 2001).  IFN-γ production is considered to be particularly 
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important in pathogenesis of Mycobacteria infections (de Almeida et al., 2008; Thacker et 
al., 2007), so the effects of 1,25(OH)2D3 on IFN-γ may have significant implications in those 
diseases.   
 Besides IFN-γ, 1,25(OH)2D3 down-regulated IL-2 production and enhanced IL-4 
production by T-cells (Bemiss et al., 2002; Cantorna et al., 1998b).  Down-regulation of IL-2 
may explain why 1,25(OH)2D3 decreases T-cell proliferation (Cantorna et al., 2004).  In 
contrast, enhancement of IL-4 may explain why 1,25(OH)2D3 enhances antibody production 
(Reinhardt et al., 1999).  Direct regulation of IL-2 and IL-4
 
production by 1,25(OH)2D3, 
however, has not been shown.   
 Several studies in mice and humans have provided evidence that 1,25(OH)2D3 
promotes development of regulatory T-cells (Ghoreishi et al., 2009; Jeffery et al., 2009; 
Unger et al., 2009).  Regulatory T-cells are characterized by FoxP3, and CTLA4 and  
1,25(OH)2D3 increased the number of FoxP3+CTLA4+ cells in human CD4+ T-cell cultures 
stimulated with anti-CD3 (Jeffery et al., 2009).  IL-10 production also is associated with a 
regulatory T-cell response (de Almeida et al., 2008).  IL-10 is a suppressor of macrophage 
activation and has been implicated in 1,25(OH)2D3-mediated inhibition mouse models of 
multiple sclerosis and inflammatory bowel disease (Froicu et al., 2006; Spach et al., 2006).  
Yet, direct regulation of IL-10 production by 1,25(OH)2D3 has not been shown and 
1,25(OH)2D3 has not been shown to act directly in regulatory T-cells. 
 Recently, IL-17A production by T-cells was shown to be down-regulated by 
1,25(OH)2D3 (Jeffery et al., 2009).  IL-17A is a member of the IL-17 family of cytokines, 
most of which are known to be produced by a specific lineage of CD4+ T-cells called TH17-
cells (Dong, 2008).  Although γδT-cells also express IL-17 cytokines (O'Brien et al., 2009).  
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IL-17A has been the most widely studied of the IL-17 cytokines and its primary functions 
seem to be activation of cytokine and chemokine genes in fibroblasts and epithelial cells and 
recruitment of neutrophils (Dong, 2008).  IL-17A has been implicated in the progression of 
multiple sclerosis (Dong, 2008).  In cattle, in vitro IL-17A production positively correlated 
with protection against tuberculosis (Vordermeier et al., 2009). 
 
Synthesis of 1,25(OH)2D3 in the immune system 
 In contrast to regulation of calcium homeostasis, which is regulated by the 
concentration of 1,25(OH)2D3 in plasma, 1,25(OH)2D3-immune responses do not seem to be 
regulated by the circulating concentration of 1,25(OH)2D3 (Hewison, 2010).  The 
concentration 1,25(OH)2D3 needed to regulate responses of bovine PBMCs in vitro was at 
least 400 pg/ml (Waters et al., 2001). The normal circulating concentration of 1,25(OH)2D3 
in cattle is 5-20 pg/ml (Horst et al., 1994).  The circulating concentration of 1,25(OH)2D3 
was shown to rise above 100 pg/ml in a case of bovine tuberculosis (Rhodes et al., 2003)  but 
did not change in cattle infused with lipopolysaccharide (LPS; Waldron et al., 2003).  
Therefore, the circulating concentration of 1,25(OH)2D3 does not reach the concentration of 
1,25(OH)2D3 that was required to regulate immune responses in PBMCs; so, regulation of 
immune responses by 1,25(OH)2D3 would likely be regulated synthesis of 1,25(OH)2D3 in 
immune cells at the site of infection. 
 Activated macrophages can synthesize 1,25(OH)2D3 from 25(OH)D3 in the human 
and murine immune systems (Hewison, 2010).  The first evidence of extra-renal synthesis of 
1,25(OH)2D3 by macrophages was shown over two decades ago when pulmonary 
macrophages from sarcoidosis patients were shown to synthesize 1,25(OH)2D3 (Adams et al., 
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1983).  In human and mouse monocytes and macrophages, 1α-OHase gene expression is 
induced by IFN-γ or toll-like receptor (TLR) recognition of pathogen-associated molecules 
(Liu et al., 2006; Stoffels et al., 2007; Stoffels et al., 2006).  Expression of 1α-OHase in 
monocytes and macrophages enabled conversion of 25(OH)D3 to 1,25(OH)2D3 (Hewison et 
al., 2007).  In human monocytes, synthesis of 1,25(OH)2D3 by 1α-OHase up-regulated 
cathelicidin gene expression and subsequently antimicrobial activity (Liu et al., 2006).  
Furthermore, it was shown that synthesis of 1,25(OH)2D3 and subsequent up-regulation of 
cathelicidin expression in activated monocytes correlated with the concentration of 
25(OH)D3 in serum from humans (Adams et al., 2009).   
 Macrophages are not the only immune cells that express 1α-OHase and synthesize 
1,25(OH)2D3.  Monocyte-derived dendritic cells were shown to express constitutively low 
amounts of 1α-Ohase, but 1α-OHase expression was increased by stimulation with LPS 
(Fritsche et al., 2003).  Dendritic cells from 1α-OHase knock out mice did not migrate to the 
lymph nodes as well as did dendritic cells from wild type mice (Enioutina et al., 2009).  
Synthesis of 1,25(OH)2D3 by dendritic cells also enhanced CCR10, a chemokine receptor, 
expression by T-cells (Sigmundsdottir et al., 2007).  Overall, synthesis of 1,25(OH)2D3 by 
1α-OHase in dendritic cells may have multiple effects on adaptive immunity through 
intracrine and paracrine mechanisms (Hewison, 2010).  Several studies have provided 
evidence for 1α-OHase expression in B-cells and T-cells, so 1,25(OH)2D3 synthesis also is 
possible in those cells (Chen et al., 2007; Sigmundsdottir et al., 2007). 
 Human keratinocytes express 1α-OHase in response to transforming growth factor-β 
(TGF-β) (Schauber et al., 2007).  Treatment of keratinocytes with 25(OH)D3 and TGF-β 
enhanced cathelicidin and CD14 gene expression (Schauber et al., 2007).  Increased 
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expression of those genes in keratinocytes depended on synthesis of 1,25(OH)2D3 by 1α-
OHase in keratinocytes. 
 Mammary epithelial cells also express 1α-OHase and synthesize 1,25(OH)2D3 
(Kemmis et al., 2006). 1α-OHase expression in mammary epithelial cells was regulated 
during development and involution of the mammary gland (Zinser and Welsh, 2004).  
Mammary epithelial cells have immune functions that can be activated by TLR signaling 
(Boulanger et al., 2001; Wellnitz and Kerr, 2004).  Therefore, bovine mammary epithelial 
cells may have the ability to synthesize 1,25(OH)2D3 in response to TLR signaling, but 
regulation of 1α-OHase expression in mammary epithelial cells in response to immune 
stimuli has not been shown.    
   
Activation of innate immunity 
 Toll-like receptor (TLR) signaling activated intracrine vitamin D signaling in human 
monocytes and macrophages (Liu et al., 2006; Stoffels et al., 2007).  TLRs are a group of 
innate receptors that recognize pathogen associated molecular patterns such as LPS from 
Gram negative bacteria, peptidoglycan from Gram positive bacteria, or double stranded RNA 
from viruses (Uematsu and Akira, 2006).  When these receptors bind their respective ligands 
they activate the immune system (Brightbill et al., 1999). In cattle there are 10 different 
TLRs, each recognizing a different molecular pattern, and they seem to be homologous to the 
human TLR family (McGuire et al., 2006).  
Of the TLR family, TLR4 has been studied the most in cattle.  TLR4 recognizes LPS 
from Gram negative bacteria (Ibeagha-Awemu et al., 2008).  Recognition of LPS by TLR4 is 
aided by CD14 and the LPS binding protein (De Schepper et al., 2008).  CD14 is mainly 
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found on the cell surface on monocytes and macrophages and, to a lesser extent, neutrophils 
(Rainard and Riollet, 2006).  The TLR2/1 and TLR2/10 heterodimers can recognize triacyl-
lipopeptides from Mycobacteria species such as M. tuberculosis (Guan et al., 2010; Takeda 
et al., 2002).  Antimicrobial activity of macrophages against M. tuberculosis is triggered by 
the TLR2/1 signaling pathway (Thoma-Uszynski et al., 2001).  The signaling mechanism of 
the TLR2/10 heterodimer, however, is not clear and is distinct from the signal transduced by 
the TLR2/1 heterodimer (Guan et al., 2010).  In contrast, the TLR2/6 heterodimer can 
recognize diacyl-lipopeptides from Mycobacteria species (Takeda et al., 2002).  Pam2CSK4 
and Pam3CSK4 (dipalmitoyl- and tripalmitoyl-cystiene,serine, lysine4) are synthetic 
lipopeptides that have been developed and are recognized by the TLR2/6 and TLR2/1 
heterodimers, respectively (Aliprantis et al., 1999).  TLR3, TLR7, and TLR8 are involved in 
recognition of viral pathogens (Kumar et al., 2009).  TLR3 recognizes double-stranded viral 
RNA and TLR7 and TLR8 will recognize single-stranded viral RNA (Kawai and Akira, 
2007).  TLR9 can recognize bacteria CpG DNA sequences, whereas TLR5 recognizes 
flagellin from bacteria (Kumar et al., 2009). 
  In general, activation of TLRs by their respective ligands triggers nuclear factor κB 
(NF-κB) and mitogen-activated protein kinase (MAPK) signaling cascades (Doyle and 
O'Neill, 2006; Weiss et al., 2008).  Activation of these pathways by TLRs typically occurs 
through myeloid differentiating factor 88 (MyD88) and toll-interleukin 1 receptor adaptor 
protein (TIRAP) (O'Neill, 2006). MyD88-independent activation of signaling cascades by 
TLRs, however, is known to occur (Ibeagha-Awemu et al., 2008).  Activation of TLR 
signaling pathways induces the transcription of genes for cytokines and chemokines in cattle.  
Interleukin-1 (IL-1), IL-6, IL-8/ CXCL8, IL-12, RANTES/CCL5 (regulated upon activation, 
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normally T-cell expressed and secreted), and tumor necrosis factor-α (TNF-α) are examples 
of cytokines and chemokines that are induced by TLR signaling in bovine macrophages and 
mammary epithelial cells (De Schepper et al., 2008; Ibeagha-Awemu et al., 2008; Lahouassa 
et al., 2007; McClenahan et al., 2006; Pareek et al., 2005; Weiss et al., 2008).   
 
Comparison of bovine, human, and murine immune systems 
 Most of what is known about vitamin D signaling in the immune system comes from 
studies in humans and mice.  However, there are some significant different differences 
among the immune systems of cattle, humans, and mice.  Recent publication of the bovine 
genome revealed that cattle have a high number of genes encoding for antimicrobial peptides 
such as 11 cathelicidin genes and over 100 defensin genes (Elsik et al., 2009).  In contrast, 
there is only one cathelicidin gene and less than 60 defensin genes in the human and mouse 
genomes.  Many of the antimicrobial peptides in cattle are constitutively expressed on the 
skin and epithelial lining of the digestive and respiratory tracts (Tetens et al., 2010; Zanetti, 
2004).   
 The prevalence of γδT-cells in cattle is another distinct difference between the 
bovine, human, and murine immune systems (Davis et al., 1996).   Unlike αβT-cells, γδT-
cells have innate abilities to recognize pathogen-associated molecular patterns (Kerns et al., 
2009; Martin et al., 2009).  γδT-cells activated through innate receptors have been shown to 
produce IFN-γ and IL-17A (Martin et al., 2009; Pietschmann et al., 2009), which are 
cytokines that are associated with TH1 and TH17 cells of the αβT-cell lineage. 1,25(OH)2D3 
decreases IFN-γ and IL-17A production and activation of both γδT-cells and αβT-cells 
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(Baeke et al., 2010; Jeffery et al., 2009; Waters et al., 2003).  Therefore, the prevalence and 
innate characteristics of γδT-cells in cattle requires consideration in regards to the effects that 
1,25(OH)2D3 has on immune function. 
 
Conclusion 
 From the time vitamin D was discovered it has been known to regulate calcium 
homeostasis.  Regulation of calcium homeostasis by vitamin D occurs by tight regulation of 
1,25(OH)2D3 synthesis in the kidney.  Numerous studies have shown a definite role for 
1,25(OH)2D3 in regulating immune resonses (Adams and Hewison, 2010). The predominant 
source of 1,25(OH)2D3 in the immune system seems to be monocytes and macrophages that 
are activated by TLR signaling (Adams et al., 2007b; Liu et al., 2007a).  In cattle, 
1,25(OH)2D3 has been shown to regulate a few immune responses, most notably down-
regulation of IFN-γ and up-regulation of nitric oxide production (Waters et al., 2001).  The 
kidneys, however, have been the only known site of 1,25(OH)2D3 synthesis in cattle.  
Evidence from studies with mouse and human monocytes and macrophages suggests that 
bovine monocytes and macrophages will produce 1,25(OH)2D3 in response to TLR signaling.  
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Figure 1.  A) Structures of vitamin D2 (plant derived) and vitamin D3 (animal derived).  B) 
Metabolic pathway of vitamin D3 showing major metabolites.  
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CHAPTER 3. PRODUCTION OF 1,25-DIHYDROXYVITAMIN D3 BY 
1α-HYDROXYLASE IN CD14+ CELLS DIRECTS PERIPHERAL 
BLOOD MONONUCLEAR CELL IMMUNE RESPONSES 
 
A paper published in the Journal of Dairy Science1 
C.D. Nelson2,5 , T.A. Reinhardt2, T.C. Thacker3, D.C. Beitz4, and J.D. Lippolis2 
 
 
Abstract 
 
In cattle, the kidney has been the only known site for production of 1,25-
dihydroxyvitamin D3 (1,25(OH)2D3) from 25-hydroxyvitamin D3 (25(OH)D3) by 1α-
hydroxylase (1α-Ohase). Based on human studies, we hypothesized that bovine monocytes 
could produce 1,25(OH)2D3 upon activation and 1,25(OH)2D3 would regulate expression of 
vitamin D responsive genes in monocytes.  First, the effects of 1,25(OH)2D3 on bovine 
monocytes isolated from peripheral blood were tested.  Treatment of non-stimulated 
monocytes with 1,25(OH)2D3 increased expression of the gene for the vitamin D 24-
hydroxylase (24-OHase) enzyme by 51 ± 13 fold, but 1,25(OH)2D3 induction of 24-OHase 
expression was blocked by lipopolysaccharide (LPS) stimulation.  Also, 1,25(OH)2D3 
increased the gene expression of inducible nitric oxide synthase (iNOS) and the chemokine 
                                                 
1
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Elsevier Science. 
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RANTES in LPS-stimulated monocytes 69 ± 13 and 40 ± 12 fold respectively.  Next, the 
ability of bovine monocytes to express 1α-OHase and produce 1,25(OH)2D3 was tested.  
Activation of monocytes with LPS, tripalmitoylated lipopeptide (Pam3CSK4), or 
peptidoglycan (PGN) caused 43 ± 9, 17 ± 3, and 19 ± 3 fold increases in 1α-OHase gene 
expression respectively.  Addition of 25(OH)D3 to LPS-stimulated monocytes enhanced 
expression of iNOS and RANTES and nitric oxide production in a dose dependent manner, 
giving evidence that activated monocytes convert 25(OH)D3 to 1,25(OH)2D3.  In conclusion, 
bovine monocytes produce 1,25(OH)2D3 in response to toll like receptor signaling and 
1,25(OH)2D3 production in monocytes increased the expression of genes involved in the 
innate immune system.  Evidence suggests that vitamin D status of cattle may be important 
for optimal innate immune function because 1,25(OH)2D3 production in activated monocytes 
and subsequent up-regulation of iNOS and RANTES expression was dependent on 
25(OH)D3 availability. 
 
Introduction 
 
For several decades now, it was known that an endocrine mechanism exists to 
regulate renal production of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) as a way to regulate 
the concentration of 1,25(OH)2D3 systemically (Horst and Reinhardt, 1983).  The primary 
function of renal 1,25(OH)2D3 production was considered maintenance of calcium 
homeostasis (Horst, 1986).  It has become evident that 1,25(OH)2D3 modulates the immune 
response of several species, including cattle (Waters et al., 2001).  Furthermore, activated 
human macrophages produce 1,25(OH)2D3 as part of the immune response to regulate 
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1,25(OH)2D3 concentration at the site of inflammation (Liu et al., 2006).  Local control of 
1,25(OH)2D3 concentration regulates genes involved in immune responses locally rather than 
systemically (Schauber et al., 2007).  Existence of a mechanism to control 1,25(OH)2D3 
production and gene expression locally in humans and mice suggests that a similar 
mechanism may exist in cattle.  
Vitamin D, acquired in the diet or by radiation of 7-dehydrocholesterol with UVB 
light in the skin, is converted to 25-hydroxyvitamin D3 (25(OH)D3) in the liver (Horst and 
Reinhardt, 1983).  The major circulating metabolite of vitamin D is 25(OH)D3 and the 
concentration of 25(OH)D3 in blood is relatively stable in cattle (Sommerfeldt et al., 1983).  
Conversion of 25(OH)D3 to 1,25(OH)2D3 is accomplished by the enzymatic activity of 1α-
hydroxylase (1α-Ohase; (Sakaki et al., 2005). 1,25(OH)2D3 is the ligand for the vitamin D 
receptor (VDR), which is activated upon binding 1,25(OH)2D3 (Reinhardt et al., 1989).  The 
activated VDR regulates expression of genes that contain functional vitamin D response 
elements (VDRE) in their promoters (Lin and White, 2004).  It is estimated that over 1,000 
genes are regulated by 1,25(OH)2D3 (Wang et al., 2005), and the VDR is present in most 
tissues and cell types (Lin and White, 2004).  Therefore, 1,25(OH)2D3 concentration is 
regulated tightly in order to control its effects on gene expression. 
The kidney was the only known source for 1,25(OH)2D3 in cattle and regulation of 
1α-OHase expression in the kidney is mainly in response to calcium homeostasis (Horst, 
1986).  In contrast, 1α-OHase was expressed in human monocytes and macrophages in 
response to activation by toll like receptor (TLR) recognition of pathogen-associated 
molecules (Liu et al., 2006).  In human macrophages, 1,25(OH)2D3 increases the expression 
of cathelicidin directly via a VDRE in the cathelicidin promoter (Gombart et al., 2005).  It 
 35
was found that 1,25(OH)2D3 induction of cathelicidin expression in human macrophages was 
necessary for killing of intracellular Mycobacteria tuberculosis (Liu et al., 2007).  In cattle, 
1,25(OH)2D3 modulated the immune response in vitro by increasing nitric oxide production 
and decreasing IFN-γ production in peripheral blood mononuclear cells (Waters et al., 2001).  
Production of 1,25(OH)2D3 in the kidney does not increase as part of the immune response in 
cattle (Waldron et al., 2003); so, if 1,25(OH)2D3 modulates the immune response in vivo, 
there would seem to be a source other than the kidney.  It was hypothesized that bovine 
monocytes express 1α-OHase and produce 1,25(OH)2D3 at the site of infection in response to 
TLR signaling to direct local regulation of vitamin D responsive genes.   The objectives were 
to assess the effects of 1,25(OH)2D3 on bovine monocytes isolated from peripheral blood and 
test the ability of bovine monocytes to express 1α-OHase and convert 25(OH)D3 to 
1,25(OH)2D3. 
 
Materials and Methods 
 
Animals 
A group of 12 healthy, mid-lactation Holstein cows at the National Animal Disease 
Center were used.  The number of cows used for each experiment ranged from 4 to 6 and is 
specified in the figure legend.  The care and treatment of the cows used were approved by the 
National Animal Disease Center animal care and use committee.   
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Monocyte isolation and culture conditions 
Monocytes were isolated by adherence to tissue culture flasks as previously described 
(Stabel et al., 1997).  Briefly, peripheral blood was collected into 2X acid citric dextrose and 
the mononuclear cell fraction was separated by density gradient centrifugation.  Cells were 
resuspended in RPMI 1640 (Sigma-Aldrich, St. Louis, MO) plus 10% fetal bovine serum 
(FBS; Hyclone, Waltham, MA) and incubated at 37°C for 1 h in tissue culture flasks. 
Lymphocytes were then removed by washing 3X with warm PBS.  Monocytes were 
dislodged from the tissue culture flasks using cold PBS plus 20 mM EDTA.  Monocytes were 
pelleted and resuspended to a concentration of 107 cells/mL in RPMI 1640 containing 50 
µg/mL gentamicin (Invitrogen, Carlsbad, CA) and placed in 24-well or 96-well non-tissue 
culture treated polystyrene plates (Becton Dickinson, Franklin Lakes, NJ)  
All treatments were added to heat-inactivated FBS at 10X the desired final 
concentration, and FBS was added to wells containing monocytes to a final concentration of 
10%.  Monocytes were incubated with the treatments for 24 h at 37°C in 5% CO2.  LPS from 
Serratia marsescens (Sigma Aldrich), Pam3CSK4 (InvivoGen, San Diego, CA), a synthetic 
tripalmitoyl lipopeptide, and peptidoglycan (PGN) from Staphylococus aureus (InvivoGen) 
were in endotoxin-free water.  Both 25(OH)D3 and 1,25(OH)2D3 (Sigma Aldrich) were 
diluted to a concentration of 100 ng/µL in 100% ethanol.  Concentrations were confirmed by 
UV spectroscopy using an extinction coefficient of 18,200 M-1 per cm. The final 
concentration of ethanol did not exceed 0.04% for any of the treatments, and a treatment of 
ethanol alone at 0.04% was used as a control for the effects of ethanol.  The lot of FBS used 
contained no more than 20 ng/mL of 25(OH)D3.  Ketoconazole (Sigma Aldrich) was 
solubilized in PBS at pH 2.5 and diluted to 50 µg/mL in PBS at pH 7.  
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Measurement of relative gene expression 
RNA was isolated from monocytes using an Rneasy Mini kit (Qiagen, Valencia, CA) 
according to manufacturer’s instructions and eluted with 50 µL of Rnase-free water.  The 
RNA was reverse transcribed to cDNA in a 20 µL reaction using a High Capacity Reverse 
Transcription kit (Applied Biosystems, Foster City, CA) with 10 µL of RNA sample and 20 
units of Rnase Inhibitor (Applied Biosystems).  Reactions were incubated at 37°C for 2 h and 
heated to 85°C for 5 s. The cDNA samples were diluted 1:10 in sterile water and stored at -
20°C. Quantitative PCR was performed with the 7300 Real-Time PCR System (Applied 
Biosystems) according to manufacturer’s instructions.  Reactions consisted of 12.5 µL 
SYBR Green PCR Master Mix (Applied Biosystems), 2.5 µL each of 10 µM forward and 
reverse primers and 7.5 µL of diluted cDNA.  Primers pairs were designed with primer3 
(http://frodo.wi.mit.edu/primer3) (Rozen and Skaletsky, 2000) to span intron-exon 
boundaries.  Primer sequences along with the efficiency of replication for each primer pair 
are in Table 1.  The efficiency of each primer pair was calculated using the equation 
Efficiency = -1 + 10(-1/slope); where slope equals the slope of a standard curve generated with 
known dilutions of cDNA in the PCR reactions.  Primer specificity was determined by gel 
electrophoresis and melting curve analysis. Relative quantification of mRNA transcripts was 
accomplished using the 2-∆∆Ct method (Livak and Schmittgen, 2001).  The gene for ribosomal 
protein S9 (RPS9) was used as the reference gene (Janovick-Guretzky et al., 2007), and 
stability of RPS9 expression was checked by comparison with β-actin expression.  For each 
experiment, the control sample was used as the calibrator, and expression of each gene is 
reported as fold increase relative to the control. 
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Measurement of nitric oxide production 
The concentration of nitrite in the culture supernatant at the end of the incubation 
period was used as an indicator of nitric oxide produced by monocytes.  Nitrite concentration 
was measured by adding 100 µL of culture supernatant or culture media with 0 to 100 µM 
sodium nitrite to 100 µL of Griess reagent (0.5% sulfanilamide, 2.5% phosphoric acid, and 
0.05% N-(1-naphthyl) ethylenediamine dihydrochloride) (Sigma Aldrich) in a 96-well clear 
bottom plate.  The reactions were incubated for 10 min at room temperature.  Absorbance at 
550 nm in each well was measured using a FlexStation 3 plate reader (Molecular Devices, 
Sunnyvale, CA).  Absorbance values were converted to micromoles per liter using a standard 
curve.  To ensure that nitrite accumulation in the culture supernatant was a result of nitric 
oxide synthase activity, 1 mM of NG-monomethyl-L-arginine (L-NMMA) (Sigma Aldrich), a 
nitric oxide synthase inhibitor, was added as a control treatment.  There was no accumulation 
of nitrite in the culture supernatant when L-NMMA was added as a treatment.   
 
Statistical analysis  
Response variables were analyzed as a completely randomized block design with 
PROC GLM (SAS Institute, Inc., Cary, NC).  The model accounted for effects of treatment 
and cow.  Experimental units were blocked according to cow to account for variation of 
monocyte responses between cows. For gene expression, ∆∆Ct values were used as the 
response variables in the analyses.  Mean ∆∆CT values ± SE were transformed (2-∆∆Ct) and 
presented as the mean fold increase relative to control.  
Multiple-comparison tests of the means were made with the Tukey adjustment. Differences 
were considered significant at P < 0.05.  
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Results 
 
Effects of 1,25(OH)2D3 on monocytes 
Initially the effect of 1,25(OH)2D3 on 24-OHase expression in monocytes was tested 
because 24-OHase is known to be a vitamin D-responsive gene. The 24-OHase expression in 
monocytes increased with 1,25(OH)2D3 treatment (P < 0.05;Figure 1A).  Surprisingly 
though, the effects of 1,25(OH)2D3 on 24-OHase expression were greatly reduced when 
monocytes were activated with LPS (P < 0.05; Figure 1A).  Potential VDREs were found in 
the promoters of the bovine Cathelicidin 4 (CATH4), CATH5 and CATH6 genes (results not 
shown) using the NHR SCAN website (http://asp.ii.uib.no:8090/cgi-bin/NHR-
scan/nhr_scan.cgi; Sandelin and Wasserman, 2005).  However, The expression of CATH4, 
CATH5, or CATH6 was not increased by 1,25(OH)2D3 treatment in non-stimulated or LPS-
stimulated monocytes (Figure 1A).  
Of the other genes tested, iNOS, RANTES, and S100A12 gene expression were up-
regulated by treatment with 4 ng/mL 1,25(OH)2D3 alone (P < 0.05; Figure 1B).  The 
combination of LPS and 1,25(OH)2D3 treatments, resulted in increases of both iNOS and 
RANTES gene expression relative to either treatment alone (P < 0.05; Figure 1B).  There 
was no synergistic effect of LPS and 1,25(OH)2D3 on S100A12 gene expression (Figure 1B).  
IL-1β gene expression increased slightly (P > 0.05) in non-activated and LPS-activated 
monocytes treated with 4 ng/mL 1,25(OH)2D3 (Figure 1B). 
In LPS-activated monocytes, RANTES expression was increased by addition of 0.04 
ng/mL (P < 0.05) of 1,25(OH)2D3 and peaked with addition of 0.4 ng/mL 1,25(OH)2D3 
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(Figure 2A).  Both iNOS expression and nitric oxide production increased with 1,25(OH)2D3 
dose in LPS-activated monocytes (P < 0.05) (Figures 2B and 2C).     
 
Expression 1α-OHase in monocytes 
The ability of bovine monocytes to express 1α-OHase upon activation with TLR 
ligands was tested.  Activation of bovine monocytes with LPS, Pam3CSK4, or PGN 
triggered a large increase in 1α-OHase gene expression relative to non-activated monocytes 
(P < 0.001; Figure 3).   
 
Activity of 1α-OHase in monocytes 
Increasing the concentration of 25(OH)D3 in the culture media to physiological 
concentrations increased RANTES and iNOS gene expression and nitric oxide production in 
LPS-stimulated monocytes in a dose-dependent manner (linear effect, P < 0.001; Figure 4).  
To determine if 1α-OHase activity is necessary for the effects of 25(OH)D3 on 
activated monocytes, ketoconazole was used to block conversion of 25(OH)D3 to 
1,25(OH)2D3.  Ketoconazole is a non-specific competitive inhibitor of 1α-OHase enzyme 
activity (Schuster et al., 2001).  Treatment with ketoconazole decreased the effects of 
25(OH)D3 on RANTES and iNOS gene expression and nitric oxide production, but not 1α-
OHase gene expression in LPS-stimulated monocytes (P < 0.05; Figure 5).  Furthermore, the 
effects of ketoconazole were reversed when exogenous 1,25(OH)2D3 was added to the 
culture media (P < 0.05).  Addition of 25(OH)D3 to monocytes that were not activated with 
LPS increased RANTES gene expression (P < 0.05) even though 1α-OHase gene expression 
was not elevated. 
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Discussion 
 
It has been known that 1,25(OH)2D3 modulates bovine immune responses by 
increasing nitric oxide production by PBMC in vitro (Waters et al., 2001).  This study more 
specifically revealed that 1,25(OH)2D3 enhanced iNOS gene expression in activated 
monocytes.  It showed for the first time that RANTES expression was increased by 
1,25(OH)2D3.  But, the concentration of 1,25(OH)2D3 needed to increase iNOS and RANTES 
was much higher than the normal concentration of 1,25(OH)2D3 in serum which is less than 
50 pg/mL  (Horst and Reinhardt, 1983).  Also, the concentration of 1,25(OH)2D3 in serum 
did not increase during infection in cattle (Waldron et al., 2003).  It was shown in this study 
that bovine monocytes converted 25(OH)D3 to 1,25(OH)2D3 in response to TLR signaling; 
providing 1,25(OH)2D3 at the site of infection.  Furthermore, physiological concentrations of 
25(OH)D3, which typically range from 20 to 50 ng/mL, were sufficient to increase iNOS and 
RANTES gene expression through the actions of 1α-OHase in monocytes.  
An interesting observation in terms of regulating 1,25(OH)2D3 concentration at the 
site of infection was the regulation of 24-OHase expression.  Inactivation of 1,25(OH)2D3 
occurred by hydroxylation at the 24 position by 24-OHase (Reinhardt and Horst, 1989).  
Expression of 24-OHase normally is up-regulated by 1,25(OH)2D3 as a means to limit the 
concentration of 1,25(OH)2D3 (Goff et al., 1992).  The same regulation of 24-OHase 
expression occurs in non-activated bovine monocytes.  Activation of monocytes with LPS, 
blocks induction of 24-OHase expression by 1,25(OH)2D3.  Without 24-OHase, 1,25(OH)2D3 
produced in monocytes will not be degraded and continue to regulate gene expression.  
Inhibition of 24-OHase expression in LPS-activated monocytes seems to amplify the effects 
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of 1,25(OH)2D3 on iNOS and RANTES gene expression.  Physiologically, this may be a 
another means to increase the concentration of 1,25(OH)2D3 at the site of infection and 
increase the expression of iNOS and RANTES and possibly other genes as well.  The 
specifics of this observation will have to be studied further to better understand the 
physiological impact.        
A major difference exists between humans and cattle in regards to the effects of 
1,25(OH)2D3 on the innate immune response.  In human monocytes, production of 
1,25(OH)2D3 increased the expression of cathelicidin, which enhanced killing of intracellular 
Mycobacteria tuberculosis (Liu et al., 2007).  In contrast, the bovine cathelicidin genes with 
potential VDREs in their promoters were not affected by 1,25(OH)2D3.  Regulation of 
cathelicidin expression by 1,25(OH)2D3 does not occur in mice either (Gombart et al., 2005) 
and is thought to be primate specific (Gombart et al., 2009).   
In cattle, production of 1,25(OH)2D3 by monocytes enhanced production of nitric 
oxide by increasing the expression of iNOS.  Nitric oxide is known to have several effects 
physiologically and was considered a fundamental component of the antimicrobial response 
(Bogdan, 2001).  Studies with iNOS-deficient mice revealed that production of nitric oxide 
aided in the resolution of M. tuberculosis and M. bovis infections (MacMicking et al., 1997, 
Waters et al., 2004).  Nitric oxide is not necessary for killing of intracellular M. tuberculosis 
in human macrophages though (Thoma-Uszynski et al., 2001), and no studies have 
definitively shown that nitric oxide is necessary for bovine macrophages to kill bacteria.  The 
primary function of nitric oxide in the bovine immune response, therefore, may be regulation 
of blood flow (Lacasse et al., 1996) and signaling (Bansal et al., 2009) rather than 
antimicrobial.  Regardless, nitric oxide production occurred during the course of several 
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major diseases of cattle such as Johne’s disease (Waters et al., 2003), mastitis (Blum et al., 
2000, Bouchard et al., 1999), and tuberculosis (Palmer et al., 2007).  The concentration of 
25(OH)D3 in cattle then may have considerable implications in such diseases because nitric 
oxide production in monocytes is dependent on 25(OH)D3 concentration in vitro. 
It was shown that 1,25(OH)2D3 production in bovine monocytes increased RANTES 
gene expression.  Also known as chemokine (C-C motif) ligand 5 (CCL5), RANTES is a 
chemo-attractant for T-helper cells and monocytes to the site of inflammation (Schall, 1991).  
RANTES was  implicated in the clearance of viral infections in humans, likely by the 
recruitment of other immune cells to the site of infection (Levy, 2009).  Little information 
exists on the importance of RANTES in the bovine immune response and most of what is 
known about the chemokine is drawn from studies in other species.  RANTES expression 
was induced by TLR signaling in cattle (Pareek et al., 2005, Widdison et al., 2008).  Based 
on evidence from this study, induction of RANTES expression in bovine monocytes was 
mediated by production of 1,25(OH)2D3 in monocytes in response to TLR signaling. 
Finally, this study provides evidence that vitamin D status of cattle is important for 
proper immune function.  It is clear that RANTES and iNOS expression and nitric oxide 
production in activated monocytes increased with 25(OH)D3 concentration up to 100 ng/mL 
in vitro.  The concentration of serum 25(OH)D3 in cattle supplemented with the 
recommended amount of dietary vitamin D typically ranges from 20 to 50 ng/mL 
(McDermott et al., 1985).  Serum 25(OH)D3 concentrations above 50 ng/mL can be reached 
by additional supplementation, so it may be possible to boost RANTES expression and nitric 
oxide production during an immune response in cattle.  When the 25(OH)D3 concentration 
exceeds 200 ng/mL in serum, calcification of soft tissue occurred (Horst et al., 1994).  
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Current dietary recommendations for vitamin D supplementation of cattle are largely based 
on the amount of vitamin D needed to maintain proper mineral homeostasis in dairy cattle, 
not for proper immune function.  Therefore, future studies are needed to determine what 
concentration of 25(OH)D3 in cattle is needed for proper immune function. 
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Tables 
 
Table 1.  Primer sequences for real-time PCR 
Gene  Accession #  Strand Sequence 5’-3’ 
Product 
size (bp) 
Primer 
Efficiency 
1α-Hydroxylase XM_588481 
F 
R 
TGGGACCAGATGTTTGCATTCGC 
TTCTCAGACTGGTTCCTCATGGCT 
80 1.09 
24-Hydroxylase  XM_591370 
F 
R 
GAAGACTGGCAGAGGGTCAG 
CAGCCAAGACCTCGTTGATT 
97 1.01 
Cathelicidin 4  NM_174827 
F 
R 
AGAGTGTCATCCTACCCTGGAA 
TTTCACTGTCCAGAAGCCCGAA 
136 0.97 
Cathelicidin 5  NM_174510 
F 
R 
GTGCTTGGAAGAAGTATGGCCCAA 
GGCCCACAATTCACCCAATTCTGA 
63 1.04 
Cathelicidin 6  NM_174832 
F 
R 
TCCAGTCATTCCGCTACTCC 
CAGAATCCAAAAGCCTGAGC 
91 1.11 
IL-1β NM_174093 
F 
R 
GCCTTGGGTATCAAGGACAA 
TTTGGGGTCTACTTCCTCCA 
90 1.04 
iNOS1 NM_001076799 
F 
R 
GATCCAGTGGTCGAACCTGC 
CAGTGATGGCCGACCTGATG 
128 0.97 
RANTES  NM_175827 
F 
R 
CACCCACGTCCAGGAGTATT 
CTCGCACCCACTTCTTCTCT 
116 1.01 
RPS9 NM_001101152 
F 
R 
GTGAGGTCTGGAGGGTCAAA 
GGGCATTACCTTCGAACAGA 
108 1.02 
S100 A12  NM_174651 
F 
R 
GCTGAAGCAGCTGATCACAA 
TCTTTATCGGCATCCAGGTC 
102 0.93 
1
 Primer sequence from (Aalberts et al., 2007). 
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Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Effects of lipopolysaccharide (LPS) and 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) 
treatment on gene expression in bovine monocytes.  Monocytes were isolated from 
peripheral blood of 4 cows and treated with 100 ng/mL LPS and 4 ng/mL 1,25(OH)2D3 as 
indicated for 24 h.  Relative expression of  (A) 24-hydroxylase (24-OHase), cathelicidin 
(CATH) 4, 5 and 6, and (B) inducible nitric oxide synthase (iNOS), interleukin-1β  (IL-1β), 
RANTES, and S100A12 was determined using real-time PCR and the 2-∆∆Ct method.  The 
mean fold increase shown for each gene is relative to the non-treated control. Error bars 
represent SE, n = 4.  Means with different letters are different, P < 0.05.  
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Figure 2. Effects of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) dose on lipopolysaccharide-
stimulated monocytes.  Peripheral blood monocytes were isolated from 6 cows and treated 
with 100 ng/mL lipopolysaccharide and 0 to 4 ng/mL of 1,25(OH)2D3 as indicated for 24 h. 
Relative expression of RANTES (A) and inducible nitric oxide synthase (iNOS; B) was 
determined using real-time PCR and the 2-∆∆Ct method.  The mean fold increase shown for 
RANTES and iNOS expression is relative to the non-treated control.  (C) Nitric oxide 
production was determined by measuring the amount of nitrite in the culture supernatant with 
the Griess assay. Error bars represent SE, n = 6.  Means with different letters are different, P 
< 0.05.  
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Figure 3.  Toll-like receptor signaling induces 1α-hydroxylase (1α-Ohase) expression in 
bovine monocytes.  Monocytes were isolated from peripheral blood of 6 cows and treated 
with 100 ng/mL lipopolysaccharide (LPS), 5 µg/mL Pam3CSK4 (Pam3), or 5 µg/mL 
peptidoglycan (PGN) for 24 h.  Relative expression of 1α-OHase was determined using real-
time PCR and the 2-∆∆Ct method.  The mean fold increase shown for 1α-OHase expression is 
relative to the non-stimulated control.  Error bars represent SE, n = 6.  ***Mean is different 
from control, P < 0.001.  
 
0
10
20
30
40
50
60
none LPS Pam3 PGN
F
o
ld
 i
n
c
re
a
s
e
*** 
*** 
*** 
1α-OHase mRNA 
Stimulant 
 51
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. RANTES, inducible nitric oxide synthase (iNOS) and nitric oxide increase with 
25-hydroxyvitamin D3 (25(OH)D3) dose.  Peripheral blood monocytes were isolated from 6 
cows and treated with 100 ng/mL lipopolysaccharide (LPS) and 0 to 100 ng/mL 25(OH)D3 as 
indicated for 24 h. Relative expression of RANTES (A) and iNOS (B) was determined using 
real-time PCR and the 2-∆∆Ct method.  The mean fold increase shown RANTES and iNOS 
expression is relative to the non-treated control.  (C) Nitric oxide production was determined 
by measuring the amount of nitrite in the culture supernatant with the Griess assay. Error bars 
represent SE, n = 6.  Means with different letters are different, P < 0.05.  *Linear effect, P < 
0.001.  
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Figure 5.  RANTES, inducible nitric oxide synthase (iNOS) and nitric oxide are dependent 
on 1α-hydroxylase (1α-Ohase) activity. Peripheral blood monocytes were isolated from 6 
cows and treated with 100 ng/mL lipopolysaccharide (LPS), 75 ng/mL 25-hydroxyvitamin 
D3 (25(OH)D3), 5 µg/mL ketoconazole, and 0.4 ng/mL of 1,25-dihydroxyvitamin D3 
(1,25(OH)2D3) as indicated for 24 h. Relative expression of 1α-OHase (A), RANTES (B) and 
iNOS (C) was determined using real-time PCR and the 2-∆∆Ct method.  The mean fold 
increase shown for each gene is relative to the non-treated control.  (D) Nitric oxide 
production was determined by measuring the amount of nitrite in the culture supernatant with 
the Griess assay. Error bars represent SE, n = 6.  Means with different letters are different, P 
< 0.05.  
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CHAPTER 3. PRODUCTION OF 1,25-DIHYDROXYVITAMIN D3 BY 
1α-HYDROXYLASE IN CD14+ CELLS DIRECTS PERIPHERAL 
BLOOD MONONUCLEAR CELL IMMUNE RESPONSES 
 
 
A paper to be submitted to the journal of Veterinary Immunology and Immunopathology 
 
Corwin D. Nelson1,3, Brian J. Nonnecke1, Timothy A. Reinhardt1, W. Ray Waters2, Donald 
C. Beitz3,4, and John D. Lippolis1. 
 
Abstract 
 
Studies in several species have shown that vitamin D contributes to immune function 
besides the well-known role it has in regulation of calcium homeostasis.  We have previously 
shown that activated bovine monocytes express 1α-hydroxylase (1α-Ohase), the enzyme that 
converts 25-hydroxyvitamin D3 (25(OH)D3) to 1,25-dihydroxyvitamin D3 (1,25(OH)2D3).  
Production of 1,25(OH)2D3 in monocytes up-regulated iNOS and RANTES gene expression.  
In other studies, IFN-γ and IL-17A production in stimulated PBMC cultures was down-
regulated by treatment with exogenous 1,25(OH)2D3. In this study we wanted to determine if 
the monocytes in stimulated PBMC cultures expressed 1α-OHase and if addition of 
25(OH)D3 to stimulated PBMC cultures could regulate IFN-γ, IL-17A, and IL-17F 
                                                 
1
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2 Bacterial Diseases of Livestock Research Unit, National Animal Disease Center, ARS, 
USDA, Ames, Iowa,  
3 Department of Biochemistry, Biophysics, and Molecular Biology, and   
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expression in addition to iNOS and RANTES expression.  PBMCs from steers that were 
vaccinated with Mycobacterium bovis (M. bovis) BCG were stimulated with a purified 
protein derivative of M. bovis (M. bovis PPD) and gene expression was measured by real-
time PCR.  Stimulation with M. bovis PPD induced 1α-OHase gene expression in PBMC 
cultures.  1α-OHase expression was induced in CD14+ cells, but not in CD14- cells.  
Treatment of stimulated PBMC cultures with 1,25(OH)2D3 or 25(OH)D3 up-regulated iNOS 
and RANTES expression.  In contrast, both 1,25(OH)2D3 and 25(OH)D3 down-regulated 
IFN-γ, IL-17A and IL-17F gene expression in stimulated PBMC cultures.  In conclusion, it 
appears that conversion of 25(OH)D3 to 1,25(OH)2D3 by 1α-OHase in monocytes can 
regulate IFN-γ, IL-17A, and IL-17F responses to stimulation in PBMCs.  
 
Introduction 
 
Vitamin D is best known for the role it has in calcium homeostasis through the 
endocrine system.  However, in recent years it has become evident that vitamin D also has an 
important role in the immune system. Vitamin D status has been linked to the autoimmune 
disorders multiple sclerosis, inflammatory bowel disease, and type 1 diabetes (Cantorna and 
Mahon 2004, Hayes 2000).  Serum 25-hydroxyvitamin D3 (25(OH)D3) concentrations, the 
primary measure of vitamin D status, also were inversely correlated with the number of 
upper respiratory track infections in people (Ginde, Mansbach and Camargo 2009).  In other 
studies, the risk of tuberculosis and influenza A infection were reduced by vitamin D 
supplementation (Martineau et al. 2007, Urashima et al. 2010).  The link between vitamin D 
status and microbial infections in people is explained by a direct effect of vitamin D 
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signaling has on immune function (Adams and Hewison 2010).  Therefore, understanding the 
mechanisms of vitamin D signaling in the bovine immune system has implications for viral 
and bacterial diseases in cattle. 
The vitamin D metabolite that regulates gene expression is 1,25-dihydroxyvitamin D3 
(1,25(OH)2D3) (Hewison 1992, Reinhardt and Hustmyer 1987). 1,25(OH)2D3 is the primary 
ligand for the vitamin D receptor (Reinhardt, Ramberg and Horst 1989).  The VDR controls 
the expression of genes that have promoters with accessible vitamin D response elements 
when activated by 1,25(OH)2D3 (Koszewski, Reinhardt and Horst 1996, Pike et al. 2007).  
The VDR is expressed in many tissues and cells throughout the body, including cells of the 
immune system (Provvedini et al. 1983, Veldman, Cantorna and DeLuca 2000).  
Examination of the human and murine genomes has revealed that nearly one thousand genes 
may be controlled through the actions of 1,25(OH)2D3 (Wang et al. 2005).  
A number of genes with known immune function are regulated by 1,25(OH)2D3. In 
human monocytes and macrophages, 1,25(OH)2D3 enhances antimicrobial activity by 
inducing cathelicidin and defensin beta 4 gene expression (Gombart, Borregaard and 
Koeffler 2005, Liu et al. 2009, Wang et al. 2004).  In activated bovine monocytes, 
1,25(OH)2D3 enhanced inducible nitric oxide synthase (iNOS) and regulated upon activation, 
normally T-cell expressed, and secreted (RANTES/CCL5) gene expression (Nelson et al. 
2010).  It has been shown on multiple occasions that 1,25(OH)2D3 suppresses antigen 
induced IFN-γ production in peripheral blood mononuclear cell (PBMC) cultures from cattle 
(Ametaj et al. 1996, Nonnecke et al. 2003, Waters et al. 2001).  Recently, 1,25(OH)2D3 was 
shown to suppress IL-17A production by human CD4 positive T-cells (Jeffery et al. 2009, 
Tang et al. 2009).  IFN-γ and IL-17A have been associated with the adaptive immune 
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response to Mycobacteria bovis (M. bovis) in cattle (Thacker, Palmer and Waters 2007, 
Vordermeier et al. 2009), so regulation of those genes by 1,25(OH)2D3 has implications in 
bovine tuberculosis.   
Regulation of vitamin D responsive genes is dependent on the concentration of 
1,25(OH)2D3.  In the vitamin D endocrine system, 1,25(OH)2D3  is produced from circulating 
25-hydroxyvitamin D3 (25(OH)D3) by 1α-hydroxylase (1α-Ohase) in the kidney (Horst, 
Goff and Reinhardt 2005).  Control of the circulating 1,25(OH)2D3 concentration occurs by 
tight regulation of 1α-OHase expression in the kidney mainly in response to calcium 
homeostasis via the parathyroid hormone (Engstrom et al. 1987).  However, several studies 
from over two decades ago showed that macrophages produce 1,25(OH)2D3 (Adams et al. 
1983, Koeffler et al. 1985). Now, evidence shows that regulation of immune responses by 
1,25(OH)2D3 occurs through intracrine and paracrine mechanisms of vitamin D signaling 
rather than through the vitamin D endocrine system (Hewison 2010).  In the case of bovine 
tuberculosis 1,25(OH)2D3 was found to accumulate in granulomas (Rhodes et al. 2003).  We 
have found that bovine monocytes express 1α-OHase in response to toll-like receptor (TLR) 
signaling (Nelson et al. 2010).  Production of 1,25(OH)2D3 from 25(OH)D3 in monocytes up-
regulated monocyte iNOS and RANTES expression.  In human monocytes, an intracrine 
mechanism of vitamin D signaling was shown to control cathelicidin and defensin beta 4 
expression (Liu et al. 2009, Liu et al. 2006).  In addition to monocytes, activated B-cells and 
T-cells also have been shown to express 1α-OHase (Chen et al. 2007, Sigmundsdottir et al. 
2007), so conversion of 25(OH)D3 to 1,25(OH)2D3 is possible in several types of immune 
cells. 
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Evidence suggests that regulation of innate and adaptive immune responses by 
1,25(OH)2D3 occurs through production of 1,25(OH)2D3 by 1α-OHase in activated immune 
cells (Hewison 2010).  However, in cattle it is not known if immune cells, other than 
monocytes, express 1α-OHase upon activation.  Conversion of 25(OH)D3 to 1,25(OH)2D3 by 
1α-OHase in monocytes regulated iNOS and RANTES gene expression, but regulation of 
gene expression by conversion of 25(OH)D3 to 1,25(OH)2D3 in PBMC cultures is not known.  
Therefore, the objectives of this study were to 1) evaluate 1α-OHase gene expression in 
PBMC cultures and 2) determine the effects of 25(OH)D3 on iNOS, RANTES, IFN-γ, IL-
17A, and IL-17F in PBMC cultures. 
 
Materials and Methods 
 
Animals 
 A group of 10 adult Holstein steers at the USDA National Animal Disease Center 
(NADC; Ames, IA) were used for this study.  The NADC animal care and use committee 
approved the care and treatment of animals for this study.  The steers were vaccinated with 
Mycobacterium bovis bacilli Calmette-Guerin (BCG) by subcutaneous injection 5 months 
prior to the experiments performed in this study. 
 
Peripheral blood mononuclear cell cultures 
 Blood from the jugular vein was collected in 2X acid citrate dextrose.  Blood was 
centrifuged and buffy coats were collected.  Contaminating RBCs were removed by 
hypotonic lysis.  PBMCs were isolated by density gradient centrifugation. PBMC were 
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resuspended in RPMI 1640 (Sigma-Aldrich, St. Louis, MO) supplemented with 50 µg/ml 
gentamicin (Invitrogen, Carlsbad, CA).  PBMCs were cultured at a concentration of 107 
cells/ml in 96-well tissue culture plates or T-25 tissue culture flasks for 24 h at 37°C in 5% 
CO2. 
 Purified protein derivative from M. bovis (M. bovis PPD) was added at 10 µg/ml to 
PBMC cultures.  The vitamin D metabolites 25(OH)D3 and 1,25(OH)2D3 (Sigma-Aldrich) 
were diluted to 100 ng/ml in 100% ethanol and added to fetal bovine serum (FBS; Hyclone, 
Waltham, MA) at 10X the final desired concentration.  The concentrations of 25(OH)D3 and 
1,25(OH)2D3 in ethanol were confirmed by UV spectroscopy.  FBS with and without the 
vitamin D metabolites was added to PBMC cultures to a final concentration of 10% FBS. 
 
Cell sorting 
 PBMCs from six steers were stimulated with M. bovis PPD for 16 h in T-25 flasks.  
Cells were removed from the flasks with cold PBS.  Cells were washed and labeled with 
mouse anti-bovine CD14 IgG1 antibody (CAM36A; VMRD, Pullman, WA) and a PE-labeled 
antibody against mouse IgG1 (Southern Biotech, Birmingham, AL).  Labeled cells were 
separated based on fluorescence intensity using the BD FACSAria Cell Sorting System (BD 
Biosciences, San Jose, CA).  Approximately 106 CD14- and CD14+ cells were collected 
from each PBMC culture.  
 
Relative gene expression 
 RNA was isolated from PBMC using the Rneasy Mini Kit (Qiagen, Valencia, CA).  
RNA samples were reverse transcribed to cDNA in 20 µl reactions using the High Capacity 
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Reverse Transcription Kit with Rnase inhibitor and random primers (Applied Biosystems, 
Foster City, CA).  The reverse transcription reactions were incubated for 2 h at 37°C 
followed by 5 s at 85°C and finally cooled to 4°C.  The cDNA samples were diluted 1:10 in 
water and stored at -20°C.   
 The amount of specific cDNA transcripts in each sample was determined using the 
7300 Real-Time PCR System (Applied Biosystems).  Each reaction contained 12.5 µl SYBR 
Green Master Mix (Applied Biosystems), 7.5 µl of cDNA sample, and 5 µl of 10 µM forward 
and 10 µM reverse primers.  Reactions were incubated as follows: 95°C for 10 min followed 
by 40 cycles of 95°C for 15 s and 60°C for 60 s.  Primer sets were designed with Primer3 
(http://frodo.wi.mit.edu/primer3) (Rozen and Skaletsky 2000) to span intron-exon boundaries 
and are listed in Table 1.  Primers were purchased from Integrated DNA Technologies 
(Coralville, IA).  The efficiency of each primer set was determined as previously described 
(Nelson et al. 2010) and fit the criteria required for quantification by real-time PCR (Livak 
and Schmittgen 2001).  The specificity of each primer set was verified by melting curve 
analysis and gel electrophoresis.  The amounts of cDNA transcripts were normalized to 
ribosomal protein S9 (RPS9) cDNA.  The relative expression of each gene was determined 
using the 2-∆∆Ct method (Livak and Schmittgen 2001).  The expression of each gene is 
relative to the normalized amount of each cDNA transcript in the non-stimulated controls for 
each experiment.   
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Statistical Analysis 
 Analysis of variance was performed using PROC GLM of SAS (SAS Institute INC., 
Cary, NC).  The model accounted for effects of treatment and steer.  For analysis of gene 
expression, ∆∆Ct values were used in the analyses.  The average ∆∆Ct values ± SE was 
transformed using the equation 2-∆∆Ct.  The expression of each gene is presented as the mean 
fold increase ± SE relative to non-stimulated controls.  Multiple comparison tests of the 
means were made using the Tukey adjustment. 
  
Results 
 
1α-OHase expression 
PBMC cultures were treated with a purified protein derivative of M. bovis (M. bovis 
PPD) for 24 hrs and 1α-OHase gene expression was measured by qPCR.  1α-OHase gene 
expression in the stimulated PBMC cultures was 8 fold higher than in the non-stimulated 
cultures (Fig. 1).  M. bovis PPD stimulated PBMCs also were sorted according to surface 
expression of CD14 by FACS to find which population of cells were expressing 1α-OHase 
(Fig. 2B-D).  1α-OHase gene expression was 80 fold higher in CD14+ cells  compared to 
CD14- cells from the stimulated PBMC cultures (Fig 2A).  Furthermore, 1α-OHase 
expression in the CD14- fraction was not different from 1α-OHase expression in non-
stimulated PBMCs. 
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Regulation of PBMC responses by vitamin D signaling 
The biologically active metabolite of vitamin D3 is 1,25(OH)2D3 and the enzymatic 
activity of 1α-OHase synthesizes 1,25(OH)2D3 from 25(OH)D3.  Circulating concentrations 
of 25(OH)D3 and 1,25(OH)2D3 in cattle under normal conditions can range from 20 to 100 
ng/ml and 5 to 50 pg/ml, respectively (Horst, Goff and Reinhardt 1994).  PBMC cultures 
were treated with M. bovis PPD and 100 ng/ml 25(OH)D3, 400 pg/ml of 1,25(OH)2D3, or 
0.04% ethanol (vehicle) for 24 hrs and iNOS, RANTE, IFN-γ, IL-17A, and IL-1F gene 
expression was measured.  iNOS and RANTES gene expression was significantly higher in 
PBMC cultures that were treated with M. bovis PPD and 25(OH)D3 or 1,25(OH)2D3 than in 
cultures that were treated with M. bovis PPD alone.  (Fig. 3A and B).  Whereas, IFN-γ, IL-
17A, and IL-17F gene expression was significantly lower in PBMC cultures that were treated 
with M. bovis PPD and 25(OH)D3 or 1,25(OH)2D3 than in cultures that were treated with M. 
bovis PPD alone (Fig. 3C-E). 
 
iNOS, RANTES, IFN-γ, IL-17A, and IL-17F expression in CD14+and CD14- cells 
The CD14+ and CD14- cells from M. bovis-stimulated PBMC cultures that were 
evaluated for 1α-OHase expression (Fig. 2) also were evaluated for iNOS, RANTES, IFN-γ, 
IL-17A, and IL-17F expression (Fig. 4).  Like 1α-Ohase, iNOS gene expression was much 
greater in the CD14+ cells than in the CD14- cells (Fig. 4A).  In contrast, IFN-γ gene 
expression was much greater in the CD14- cells than in the CD14+ cells (Fig. 4C). RANTES, 
IL-17A and IL-17F expression was greater in the CD14- than in the CD14+ cells, but the 
difference was not significant (Fig. 4B, D and E).  
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Discussion 
 
Several studies have shown that 1,25(OH)2D3 regulates genes that are important for 
innate and adaptive immunity in cattle (Nelson et al. 2010, Waters et al. 2001).  Expression 
of 1α-OHase in immune cells allows for intracrine and paracrine control of 1,25(OH)2D3-
mediated immune responses rather than endocrine control.  In this study, we showed that 1α-
OHase expression was induced in the CD14+ cells (monocytes) in PBMC cultures that were 
stimulated with M.bovis PPD.  Subsequently, addition of 25(OH)D3 regulated expression of 
several genes that have an important role in immune function.  In a previous study we 
showed that regulation of gene expression in monocytes by treatment with 25(OH)D3 
depended on conversion of 25(OH)D3 to 1,25(OH)2D3 by 1α-OHase in monocytes (Nelson et 
al. 2010).  Therefore, regulation of gene expression by addition of 25(OH)D3 in this study 
evidently occurred by synthesis of 1,25(OH)2D3 by 1α-OHase in monocytes. 
Data from this study indicates that synthesis of 1,25(OH)2D3 by 1α-OHase in 
monocytes up-regulated iNOS and RANTES expression in stimulated PBMC cultures.  
Previously we showed that synthesis of 1,25(OH)2D3 in monocytes up-regulated iNOS and 
RANTES expression in monocytes (Nelson et al. 2010).   However, RANTES was originally 
discovered as a T-cell cytokine (Schall et al. 1988), so in PBMC cultures 1,25(OH)2D3 
produced in monocytes also may act on T-cells to up-regulate RANTES expression.  Up-
regulation of RANTES may enhance attraction of other immune cells to the site of an 
infection, whereas, up-regulation of iNOS may enhance nitric oxide-mediated antimicrobial 
activity and signaling of macrophages (Bogdan 2001, Levy 2009).  
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In contrast to iNOS and RANTES, 25(OH)D3 down-regulated IFN-γ expression in 
stimulated PBMC cultures.  Several previous studies have shown that exogenous 
1,25(OH)2D3 down-regulated antigen-specific IFN-γ expression in PBMCs (Ametaj et al. 
1996, Nonnecke et al. 2003, Waters et al. 2001).  However, this is the first study to give 
evidence that endogenous synthesis of 1,25(OH)2D3 down-regulates IFN-γ expression in 
PBMCs. IFN-γ is considered a T-cell cytokine and is associated with disease severity in 
bovine tuberculosis (Thacker et al. 2007, Vordermeier et al. 2002).  Therefore, synthesis of 
1,25(OH)2D3 in monocytes may have an important role in the pathogenesis of tuberculosis by 
regulating IFN-γ expression in T-cells.    
Like IFN-γ, IL-17A and IL-17F were down-regulated by 25(OH)D3.  Down-
regulation of IL-17A by 1,25(OH)2D3 has been observed in human T-cells (Jeffery et al. 
2009), but this is the first study to show that either 25(OH)D3 or exogenous 1,25(OH)2D3 
down-regulate IL-17A and IL-17F responses in cattle.  IL-17 cytokines are predominantly 
expressed by TH17-cells but also are known to be expressed by γδT-cells (Dong 2008).  IL-
17A and IL-17F induce antimicrobial and chemokine responses in fibroblasts and epithelial 
cells and are involved in the recruitment and maturation of neutrophils in mice (Kao et al. 
2004, Laan et al. 1999, Chang and Dong 2009).  In cattle, IL-17A expression in vitro 
positively correlated with protection against bovine tuberculosis in vaccinated animals 
(Vordermeier et al. 2009).  Synthesis of 1,25(OH)2D3 in monocytes, then, also may have a 
critical role in the pathogenesis of tuberculosis by regulating IL-17A and IL17F expression.  
An important environmental factor that could affect regulation of immune responses 
by 1,25(OH)2D3  is acquisition of vitamin D3.  Vitamin D3 is acquired in the diet or by 
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conversion from 7-dehydrocholesterol in skin exposed to ultra-violet B (Horst and Reinhardt 
1983).  Acquisition of vitamin D3 affects the circulating concentration of 25(OH)D3.  In this 
study we showed that expression of several genes that have a role in immune function were 
affected by treatment with a physiological concentration of 25(OH)D3.  Current 
recommendations for vitamin D in cattle target a range of 20 to 50 ng/ml of 25(OH)D3 in 
plasma (NRC 2001). Vitamin D requirements in cattle are based on vitamin D signaling in 
the endocrine system and control of calcium homeostasis.  Plasma 25(OH)D3 concentrations 
below 20 ng/ml are considered deficient for maintenance of the vitamin D endocrine system.  
However, the minimal requirement for vitamin D may be higher for the immune system.  In 
fact, plasma 25(OH)D3 concentrations below 30 ng/ml in humans are now considered 
insufficient for proper vitamin D signaling in the immune system (Adams and Hewison 2010, 
Holick 2008, Hollis 2005). Therefore, the requirement for vitamin D in cattle needs to be re-
evaluated to account for the effects of vitamin D status on the immune system.   
 
Conclusion 
Evidence from this study suggests that vitamin D signaling in the immune system 
controls several key aspects of innate and adaptive immunity in cattle.  Therefore, vitamin D 
signaling in the immune system and vitamin D status may be important factors in the defense 
against viral and bacterial diseases in cattle.  However, more investigation is needed to define 
vitamin D requirements for proper immune function and to find other genes that are regulated 
by 1,25(OH)2D3 in the immune system.     
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Tables 
 
Table 1.  Primer sequences for real-time PCR. 
Gene Accesion no.1 Strand Sequence (5′ - 3′) 
1α-Ohase2 XM_588481 Forward Reverse 
TGGGACCAGATGTTTGCATTCGC 
TTCTCAGACTGGTTCCTCATGGCT 
IFN-γ NM_174086 Forward Reverse 
GATTCAAATTCCGGTGGATG 
GCAGGAGGACCATTACGTTG 
IL-17A3 NM_001008412 Forward Reverse 
TCCATCTCACAGCGAGCACAAG  
AGCCACCAGACTCAGAAGCAGTA 
IL-17F XM_582420 Forward Reverse 
CTCCCCTTGGGATTACAACA 
TTCAGGGTCCTGTCTTCCTG 
iNOS2 NM_001076799 Forward Reverse 
GATCCAGTGGTCGAACCTGC 
CAGTGATGGCCGACCTGATG 
RANTES2 NM_175827 Forward Reverse 
CACCCACGTCCAGGAGTATT 
CTCGCACCCACTTCTTCTCT 
RPS92 NM_001101152 Forward Reverse 
GTGAGGTCTGGAGGGTCAAA 
GGGCATTACCTTCGAACAGA 
1Accesion numbers for mRNA sequences from NCBI datatbase. 
2Primer sequences have been published previously (Nelson et al. 2010). 
3Primer sequences have been published previously (Raffatellu et al. 2007). 
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Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 1α-hydroxylase (1α-Ohase) gene expression in PBMC cultures.  PBMC cultures 
from 8 steers were treated with 0 or 10 µg/ml of M. bovis purified protein derivative (PPD) 
as indicated for 24 h. The amount of 1α-OHase mRNA was determined by quantitative real-
time RT-PCR and was normalized to the amount of RPS9 mRNA in each sample.  
Expression of 1α-OHase is relative to non-stimulated cultures.  Error bars represent SE.    
*** Mean is different from non-stimulated PBMC; P < 0.001.    
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Figure 2.  Evaluation of 1α-hydroxylase (1α-Ohase) gene expression in PBMC sub-
populations.  PBMC cultures from 6 steers were treated with 10 µg/ml of M. bovis PPD for 
24 h and sorted by FACS according to CD14 expression on the cell surface.  (A) The amount 
of 1α-OHase mRNA was determined by quantitative real-time RT-PCR and was normalized 
to the amount of RPS9 mRNA in each sample.  Expression of 1α-OHase is relative to 1α-
OHase expression in non-stimulated cultures.  Error bars represent SE.  *** Mean is different 
from CD14- cells; P < 0.001.  (B-D) Representative histogram and scatter plots of stimulated 
PBMCs labeled with the CD14 antibody (CAM36A) and the PE conjugated secondary 
antibody.  
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Figure 3.  Effects of 1,25(OH)2D3 and 25(OH)D3 on gene expression in PBMC cultures.  
PBMC cultures from 8 steers were treated with 0 or 10 µg/ml of M. bovis purified protein 
derivative (PPD), 400 pg/ml 1,25(OH)2D3 and 100 ng/ml of 25(OH)D3 as indicated for 24 h.  
The amount iNOS, RANTES, IFN-γ, IL17A, IL-17F mRNA was determined by quantitative 
real-time RT-PCR.  Each gene was normalized to the amount of RPS9 mRNA in each 
sample.  Expression of each gene is relative to non-stimulated cultures.  Error bars represent 
SE, n = 8.  * Mean is different from PBMC cultures treated with M. bovis PPD alone.  
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Figure 4.  PBMC cultures from 6 steers were treated with 10 µg/ml of M. bovis purified 
protein derivative (PPD) and sorted by FACS according to CD14 expression on the cell 
surface as in figure 2.  The amount of iNOS, RANTES, IFN-γ, IL-17A, and IL-17F was 
determined by quantitative real-time RT-PCR.  The amount of mRNA for each gene was 
normalized to the amount of RPS9 mRNA in each sample.  Expression of each gene is 
relative to non-stimulated cultures.  Error bars represent SE.  * Means are different; P < 
0.001.  
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CHAPTER 4. CD14+ CELLS IN THE BOVINE MAMMARY GLAND 
EXPRESS 25-HYDROXYVITAMIN D 1α-HYDROXYLASE DURING 
BACTERIAL MASTITIS 
 
A paper to be submitted for publication 
Corwin D. Nelson1,2, Timothy A. Reinhardt1, Donald C. Beitz2,3, John D. Lippolis1 
 
Abstract 
The active vitamin D metabolite, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), is an 
important regulator of immune function. The enzyme that synthesizes 1,25(OH)2D3 from 25-
hydroxyvitamin D3 is 1α-hydroxylase (1α-Ohase; CYP27B1).  Several in vitro studies have 
shown that TLR signaling induces expression of 1α-OHase in monocytes and macrophages.  
Synthesis of 1,25(OH)2D3 in monocytes and macrophages presumably allows for local 
control of 1,25(OH)2D3-mediated gene expression.  However, induction of 1α-OHase 
expression at the site of an infection has not been shown.  Using Streptococcus uberis 
mastitis in cattle as a model of bacterial infection, we measured 1α-OHase gene expression in 
mammary tissue and cells isolated from the milk during mastitis.  In tissue and secreted cells 
from the infected mammary glands, 1α-OHase gene expression was much higher compared 
to expression in tissue and cells from the healthy glands.  Separation of the cells by 
fluorescence activated cell sorting (FACS), revealed that 1α-OHase was predominantly 
expressed in the CD14+ cells from the infected gland.  Finally, 24-hydroxylase, inducible 
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nitric oxide synthase (iNOS), and RANTES (regulated upon activation, normally T-cell 
expressed and secreted; CCL5), genes that are upregulated by 1,25(OH)2D3 in cattle, were 
expressed significantly more in tissue and cells from the infected glands than from the 
healthy glands.  In conclusion, 1α-OHase is upregulated in CD14+ cells in an infected 
mammary gland during mastitis and seems to provide 1,25(OH)2D3 for local regulation of 
1,25(OH)2D3-mediated immune responses.  To our knowledge, this study provides the first in 
vivo evidence that 1α-OHase expression is upregulated in macrophages in response bacterial 
infection.     
 
Introduction 
 
 Vitamin D has been shown to have a role in regulating immune function in addition 
to the well-known role it has in regulating calcium homeostasis.  1,25-dihydroxyvitamin D3 
(1,25(OH)2D3), the active vitamin D3 metabolite, regulates the expression of several genes 
involved in host defense and immune function (Adams and Hewison, 2010).  Therefore, 
synthesis of 1,25(OH)2D3 to control vitamin D responsive genes in immune cells is a critical 
factor in regulating of immune function.   
The enzyme that synthesizes 1,25(OH)2D3 from 25-hydroxyvitamin D3 (25(OH)D3), 
the major vitamin D3 metabolite in plasma, is 1α-hydroxylase (1α-Ohase; CYP27B1) (Horst 
et al., 2003).  In the kidney, 1α-OHase expression is induced by parathyroid hormone in 
response to calcium homeostasis (DeLuca, 1975; Engstrom et al., 1987).  Synthesis of 
1,25(OH)2D3 in the kidney regulates the circulating concentration of 1,25(OH)2D3 and the 
endocrine actions of vitamin D.  In monocytes and macrophages, 1α-OHase is expressed in 
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response to activation by IFN-γ or TLR signaling (Krutzik et al., 2008; Liu et al., 2006; 
Nelson et al., 2010; Stoffels et al., 2007).  Conversion of 25(OH)D3 to 1,25(OH)2D3 by 1α-
OHase in monocytes regulates the expression of vitamin D responsive genes in an intracrine 
and paracrine manner (Hewison, 2010).  In human monocytes, production of 1,25(OH)2D3 by 
1α-OHase drives cathelicidin gene expression (Liu et al., 2006).  In the same way, 1α-OHase 
activity in bovine monocytes enhances iNOS and RANTES gene expression (Nelson et al., 
2010).  From in vitro studies, expression of 1α-OHase by macrophages at the site of an 
infection seems to be an important part of innate immunity.  However, no studies have shown 
that 1α-OHase is expressed at the site of a bacterial infection.     
Mastitis in cattle offers a model of bacterial infection to determine if 1α-OHase is 
expressed in response to bacterial infection in vivo.  Mastitis is defined as inflammation of 
the mammary gland and is most often caused by bacterial infection (Bradley, 2002).  
Common pathogens that cause mastitis include Escherichia coli, Staphylococcus aureus, and 
Streptococcus uberis (Hogan and Larry Smith, 2003; Olde Riekerink et al., 2008; Petrovski 
et al., 2009; Sampimon et al., 2009).  During acute mastitis the number of somatic cells 
secreted in milk will often exceed 106 cells/mL.  Approximately 80 to 90 percent of somatic 
cells in milk from an infected gland are neutrophils and the remainder of the cells are 
macrophages and lymphocytes (Riollet et al., 2000).  The advantage of using mastitis is that 
the infiltrating cells during mastitis can easily isolated from milk using non-invasive 
procedures; allowing us to study the in vivo immune responses of immune cells to bacterial 
infection.   
TLRs are present in the bovine mammary gland (Reinhardt and Lippolis, 2006) and 
invasion of the mammary gland by bacteria triggers an innate immune response by TLR 
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signaling (De Schepper et al., 2008). Based on in vitro evidence that 1α-OHase expression in 
macrophages is induced by TLR recognition of bacteria (Liu et al., 2006; Nelson et al., 2010; 
Stoffels et al., 2006), we hypothesized that 1α-OHase expression would be upregulated in 
macrophages during mastitis.  Using mastitis in cattle as a model of bacterial infection, we 
give the first in vivo evidence that 1α-OHase expression is upregulated in CD14+ cells that 
are at the site of a bacterial infection.     
 
Materials and Methods 
 
Animals  
Eight, mid-lactation Holstein cows at the USDA National Animal Disease Center 
were used for this study.  The National Animal Disease Center Animal Care and Use 
Committee approved all procedures used in this study.  Prior to the study, all cows were 
healthy and bacteria were not detected in their milk.  Mastitis was induced by infusion of 500 
cfu of Streptococcus uberis strain 0140 (S. uberis; a gift from Dr. Max Paape, USDA, 
Beltsville, MD) suspended in 3 mL of PBS into one mammary gland.  The contra-lateral 
gland was infused with an equal volume of PBS and served as the control.  The amount of S. 
uberis in the milk from the control and infected glands was determined by culturing log 
dilutions of milk samples on blood agar plates for 24 hours at 37°C.  
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Collection of tissue and cells   
Mammary tissue was collected from various locations in the control and infected 
glands of three cows that were euthanized at the onset of clinical mastitis.  Clinical mastitis 
was defined by rectal temperature, noticeable inflammation, and presence of bacteria in the 
milk.  Tissue was placed in RNAlater (Qiagen, Valencia, CA), snap frozen in liquid nitrogen 
and stored at -80°C.   
 Cells were isolated from milk from the control and infected glands and 
peripheral blood of 5 cows before infection with S. uberis and at the onset of clinical mastitis.  
Cells were isolated from milk by centrifuging the milk at 1000Xg for 20 min.  Peripheral 
blood leukocytes were isolated by lysing the erythrocytes with a hypotonic buffer and 
centrifuging at 650Xg for 10 min. The cell pellets from milk and blood were washed 3X by 
resuspending in cold PBS and centrifuging at 650Xg for 10 min.  Cells were lysed with RLT 
buffer (Qiagen) and stored at -80°C or separated by fluorescence activated cell sorting 
(FACS).  
For separation of cells from blood and milk by FACS, cells were labeled with 
monoclonal anti-bovine CD14 IgG1 (CAM36A; VMRD, Inc., Pullman, WA) and a PE-
conjugated anti-mouse IgG antibody (Southern Biotech, Birmingham, AL).  Labeled cells 
were separated based on fluorescence intensity using the BD FACSAria Cell Sorting System 
(BD Biosciences, San Jose, CA).  Approximately 106 CD14+ and CD14- cells with greater 
than 95% purity were isolated from the infected gland of each animal.  The sorted cells were 
lysed with RLT buffer (Qiagen) and stored at -80°C.     
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Real-time PCR   
RNA was isolated from mammary tissue and cells by using an Rneasy Mini Kit 
(Qiagen).  RNA samples were eluted in 50 µL of RNAse-free water.  Immediately after 
elution, RNA was reverse transcribed to cDNA by using a High Capacity Reverse 
Transcription Kit (Applied Biosystems, Foster City, CA) with 10 µL RNA sample and 20 
units of Rnase inhibitor (RNaseOUT, Invitrogen, Carlsbad, CA) in a 20-µL reaction.  
Reactions were incubated at 37°C for 2 h and heated to 85°C for 5 s.  The cDNA samples 
were diluted 1:10 in water and stored at -20°C.  Real-time PCR was performed by using a 
7300 Real-Time PCR System (Applied Biosystems).  The reactions were incubated at 95°C 
for 10 min followed by 40 cycles of 95°C for 15s and 60°C for 1 min. Each reaction 
contained 12.5 µL SYBR Green PCR Master Mix (Applied Biosystems), 2.5µL each of 10 
µM forward and reverse primers, and 7.5 µL of diluted cDNA.  Sequences for primer pairs in 
5´ to 3´ order were: 1α-hydroxylase (1α-Ohase/CYP27B1) forward 
TGGGACCAGATGTTTGCATTCGC, reverse TTCTCAGACTGGTTCCTCATGGCT; 24-
hydroxylase (24-OHase/CYP24A1) forward GAAGACTGGCAGAGGGTCAG, reverse 
CAGCCAAGACCTCGTTGATT; β-actin forward GGCATCCTGACCCTCAAGTA, 
reverse CACACGGAGCTCGTTGTAGA; iNOS forward GATCCAGTGGTCGAACCTGC, 
reverse CAGTGATGGCCGACCTGATG; RANTES forward 
CACCCACGTCCAGGAGTATT, reverse CTCGCACCCACTTCTTCTCT; ribosomal 
protein S9 (RPS9) forward GTGAGGTCTGGAGGGTCAAA, reverse 
GGGCATTACCTTCGAACAGA; vitamin D receptor (VDR) forward 
AGCCACCGGCTTCCATTTCA, reverse AACAGCGCCTTCCGCTTCAT.  Primers were 
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purchased from Integrated DNA Technologies (Corralville, IA).  The specificity of each 
primer pair was determined by gel electrophoresis of cDNA products and efficiency was 
determined by using known dilutions of cDNA.  All primer pairs, except for the VDR, have 
been used previously (Nelson et al., 2010).  Relative gene expression was determined using 
the 2-∆∆Ct method (Livak and Schmittgen, 2001).  RPS9 was used as the reference gene.  
RPS9 gene expression also was compared to β-actin gene expression and the relative 
expression of RPS9 did not differ significantly among treatments.  
 
Statistical analysis   
Statistical analysis was performed by using PROC GLM of SAS (SAS Institute Inc., 
Cary, NC).  The model used in the analysis accounted for effects of treatment and cow. ∆∆Ct 
values were used to analyze relative gene expression.  Mean ∆∆Ct values ± SE were 
transformed (2-∆∆Ct) and shown as the expression relative to the control.  The control 
treatment is designated in the figure legends.  Multiple comparison tests of the means were 
made with the Tukey-Kramer adjustment. 
 
Results 
 
Streptococcus uberis mastitis  
On separate occasions, 8 cows were infused with 500 CFUs of S. uberis strain 0140 
in one mammary gland and sterile PBS in the contra-lateral gland.  Bacteria were not 
detected in milk from any of the glands prior to infection and were not detected in the milk 
from the control glands during mastitis (Fig. 1A).  The average amount of S. uberis in the 
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milk from the infected glands during mastitis was 108 CFU/mL (Fig. 1A).  Prior to infection 
cows had normal body temperatures, but during mastitis body temperatures were elevated 
(Fig. 1B).  The number of somatic cells in the milk from the infected glands rose from an 
average of 105 cells/mL prior to infection to over 107 cells/mL during mastitis (Fig. 1C).  The 
number of somatic cells in the control glands remained near 105 cells/mL on average during 
mastitis (Fig. 1C).  Examination of mammary tissue by microscopy revealed inflammation 
and the presence of infiltrating cells in the alveoli of the infected mammary gland (Fig. 1D).  
The onset of mastitis was typically 3 days after infection with S. uberis; which was consistent 
with previous studies wit S. uberis (Bannerman et al., 2004).  Therefore, mastitis was 
effectively induced in these cows by infusion of S. uberis into the mammary gland. 
 
1α-Hydroxylase gene expression during mastitis   
At the onset of clinical mastitis, secretory mammary tissue was collected from the 
control and infected glands of 3 cows.  In the tissue from the infected mammary glands, 1α-
OHase expression was nearly 50 fold greater than 1α-OHase expression in tissue from the 
healthy glands (P < 0.001; Fig. 2A).  The alveoli in the infected mammary tissue were 
packed with infiltrating cells (Fig. 1D); so, we isolated cells from the milk of control and 
infected glands to determine the contribution of infiltrating cells on 1α-OHase gene 
expression during mastitis.  In cells isolated from milk from the inflamed glands, 1α-OHase 
gene expression was 40 fold greater than expression in cells from the healthy gland (P < 
0.001) and over 300 fold greater than peripheral blood leukocytes (P < 0.001) Fig. 2B).  
Finally, separating the cells according to CD14 expression revealed that 1α-OHase was 
predominantly expressed in the CD14+ cells from the infected glands (P < 0.001 compared to 
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CD14- cells from the infected gland), but not in CD14+ cells from peripheral blood (Fig. 2C).  
CD14 is a marker for monocytes and macrophages (Brodersen et al., 1998) and typically 
10% of the cells isolated from the milk of the infected gland were CD14+ cells (Fig. 2D – F).  
 
Expression of the VDR and vitamin D responsive genes during mastitis   
The effects of 1,25(OH)2D3 on gene expression depend on the presence of the VDR.  
We measured VDR gene expression to find if it was more abundant in the infected mammary 
gland. VDR expression was slightly higher in mammary tissue from the infected gland than 
in tissue from the control gland (Fig. 3A).  However, VDR expression in the cells isolated 
from milk of the infected gland was 8 fold higher than VDR expression in cells from the 
control gland (P < 0.05) and 75 fold higher than VDR expression in peripheral blood 
leukocytes (P < 0.001; Fig. 3B).  In the cells from the inflamed gland, there was an 
insignificant difference of VDR expression between the CD14+ and CD14- populations (Fig. 
3C).  In both populations though, VDR expression was at least 50 fold greater in the cells 
from the inflamed gland than in peripheral blood leukocytes (P < 0.05).     
Expression of the gene for 24-hydroxylase (24-OHase), the enzyme that deactivates 
1,25(OH)2D3, is very responsive to 1,25(OH)2D3 (Nelson et al., 2010).  In mammary tissue, 
24-OHase expression was 50 fold higher in the inflamed glands relative 24-OHase 
expression in the control glands (P < 0.001; Fig. 4A).  The difference in 24-OHase 
expression in cells isolated from milk was not as great, but was still 4 fold higher in cells 
from the inflamed gland than in cells from the control gland or peripheral blood (P < 0.05; 
Fig. 4B).  In our previous study, we observed that 24-OHase expression was not upregulated 
by 1,25(OH)2D3 in LPS-activated monocytes (Nelson et al., 2010).  During mastitis, 24-
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OHase expression was not significantly higher in CD14+ cells from the infected glands 
compared to the CD14+ cells from blood, but was higher in CD14- cells from the infected 
glands compared to CD14- cells from blood (P < 0.05; Fig. 4C).    
In activated bovine monocytes, 1,25(OH)2D3 increases expression of iNOS and 
RANTES (Nelson et al., 2010); so, we measured the expression of both genes in mammary 
tissue and cells from the control and infected glands (Fig. 4D-I).  iNOS and RANTES 
expression was greater (P < 0.001 for iNOS and P < 0.05 for RANTES) in tissue and cells 
from the inflamed glands than in tissue or cells from the control glands.  Like 1α-OHase, 
iNOS was predominantly expressed in the CD14+ cells from the infected gland (P < 0.001 
compared to CD14- cells from the infected glands).  RANTES, however, was expressed more 
in the CD14- population from the infected glands compared with CD14+ cells from the 
infected glands (P < 0.05).  
 
Discussion 
 
Several studies have shown that 1α-OHase expression in monocytes and macrophages 
is induced by TLR signaling (Liu et al., 2006; Nelson et al., 2010; Stoffels et al., 2006), 
however, this is the first study to show that 1α-OHase expression is up-regulated at the site of 
a bacterial infection.  Evidence from this study also indicates that CD14+ cells are the 
predominant cell type that express 1α-Ohase, and subsequently produce 1,25(OH)2D3, in 
response to bacterial infection. In addition, VDR gene expression was elevated in the cells 
isolated from the milk from the infected mammary gland; which would seemingly enhance 
their sensitivity to the 1,25(OH)2D3 produced in the infected mammary gland.  Upregulation 
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of 1α-OHase and VDR expression in the infected mammary glands indicates that regulation 
of gene expression by 1,25(OH)2D3 can be controlled locally by the innate immune system.  
Regulation of vitamin D signaling in the innate immune system, in that case, is distinct from 
the endocrine system where 1,25(OH)2D3 is produced in the kidney and acts systemically to 
regulate gene expression.  
In the infected mammary glands 24-OHase, iNOS, and RANTES gene expression 
was upregulated; which gives evidence that 1,25(OH)2D3 was produced in the infected 
mammary gland.  Upregulation of 24-OHase, in particular, provides evidence that 
1,25(OH)2D3 was produced in the mammary gland during mastitis because 24-OHase 
expression is known to be highly upregulated by 1,25(OH)2D3 (Reinhardt et al., 1999; 
Vaisanen et al., 2005).  Similarly, iNOS and RANTES expression are enhanced by 
1,25(OH)2D3 in activated bovine monocytes (Nelson et al., 2010); so, they are presumably 
upregulated by 1,25(OH)2D3 in the mammary gland.  Altogether, 1α-OHase expression in the 
infected mammary gland seems to enable site-specific regulation of genes that are involved 
in host defense. 
The substrate for 1α-OHase is 25(OH)D3, so production of 1,25(OH)2D3, and 
subsequent regulation of gene expression by 1,25(OH)2D3, depends on the availability of 
25(OH)D3.  The circulating concentration of 25(OH)D3 depends on dietary intake of vitamin 
D and exposure to sunlight (Horst and Reinhardt, 1983; Wagner et al., 2008).  In cattle 
supplemented with the recommended amount of vitamin D, the circulating concentration of 
25(OH)D3 is similar to that in humans and typically ranges from 20 to 50 ng/mL (McDermott 
et al., 1985).  In the absence of dietary intake, however, the circulating concentration of 
25(OH)D3 changes greatly with season in northern latitudes and will be consistently low in 
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cattle that do not receive sun exposure (Hymoller et al., 2009).  Similar observations also 
have been made in regards to vitamin D status in people (Basile et al., 2007; Holick, 2008; 
Sherman et al., 1990).  Meanwhile, it is evident that 1,25(OH)2D3-mediated immune 
responses are dependent on the availability of 25(OH)D3 (Adams et al., 2009; Nelson et al., 
2010).  Without adequate supplementation of vitamin D, regulation of immune responses by 
1,25(OH)2D3 depends on sun exposure and is subject to seasonal variation.  
Finally, additional work is needed to determine how much vitamin D is necessary for 
optimal immune function.  In cattle, 20 ng/mL of 25(OH)D3 in plasma has been considered 
adequate for calcium homeostasis (NRC, 2001).  For proper immune function, however, 20 
ng/mL may not be sufficient.  In fact, circulating 25(OH)D3 concentrations below 30 ng/mL 
are now considered insufficient for humans (Adams and Hewison, 2010; Holick and Chen, 
2008; Hollis, 2005).  Currently, there is not information to indicate what circulating 
concentration of 25(OH)D3 is necessary for proper immune function in cattle.  In regards to 
immune function in humans, a target range for 25(OH)D3 also still remains elusive because 
of the inability to perform tightly controlled experiments.  Therefore, efforts to find the 
optimal range of 25(OH)D3 concentration for proper immune function in cattle are necessary 
and may have implications for human health.     
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Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Induction of mastitis with Streptococcuuberis.  Five hundred CFU of S. uberis 
strain 0140 were infused into the mammary glands of 8 healthy cows.  The contra-lateral 
glands were infused with 3 mL of PBS and served as the controls.  Prior to infection, all 
glands were free of bacteria.  The average CFU of S. uberis in milk (A), rectal temperatures 
(B), and number of somatic cells in milk (C) prior to infection and during mastitis are shown.  
Error bars represent the SE. (D) Representative tissue sections at 20X magnification from the 
control and infected mammary glands of one the cows with mastitis. 
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Figure 2. 1α-OHase gene expression during mastitis. The relative amount of 1α-OHase 
mRNA was determined by quantitative real-time RT-PCR and the 2-∆∆Ct method.  (A) 
Seventy-two hours after infusion 3 cows were euthanized and tissue was collected form 
various locations in the control and infected glands. 1α-OHase expression is relative to 1α-
OHase expression in control tissue.  (B) Cells were isolated from peripheral blood and milk 
of the control and infected glands of 5 cows prior to infection and during mastitis. 1α-OHase 
expression is relative to 1α-OHase expression in peripheral blood leukocytes during mastitis.  
(C) Cells from blood and milk of the infected glands of 5 cows were separated according to 
CD14 expression on the cell surface using FACS.  1α-OHase expression is relative to 1α-
OHase expression in peripheral blood leukocytes during mastitis.  ANOVA performed by 
SAS using the general linear model and multiple comparison tests were made using the 
Tukey adjustment.  Error bars represent the SE,  ***Mean is different from other means, P < 
0.001.  (D) Representative histogram of CD14 expression on cells isolated from the milk 
from the infected gland.  (E and F) Scatter plots of all cells and CD14+ cells isolated from 
milk from an infected gland.  
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Figure 3. VDR gene expression during mastitis.  The relative amount of VDR mRNA was 
determined by quantitative real-time RT-PCR and the 2-∆∆Ct method.  Tissue and cells were 
collected as in figure 2. (A) VDR expression in tissue from control and infected glands.  
VDR expression is relative to the amount of VDR in control tissue.  (B) VDR gene 
expression in cells from milk and peripheral blood prior to infection and during mastitis.  
VDR expression is relative to the amount of VDR in peripheral blood leukocytes during 
mastitis.  (C) VDR gene expression in cells from blood and milk from infected glands 
separated according to CD14 protein expression.  VDR expression is relative to the amount 
of VDR in peripheral blood leukocytes during mastitis. ANOVA performed by SAS using 
the general linear model and multiple comparison tests were made using the Tukey 
adjustment. Error bars represent the SE, *Mean is different from other means, P < 0.05.  
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Figure 4. Relative gene expression of 24-OHase (A-C), iNOS (D-F), and RANTES (G-I) in 
mammary tissue and cells from peripheral blood and milk during mastitis.  Tissue and cells 
were collected as in figure 2. The relative amount of mRNA for each gene was determined 
by quantitative real-time RT-PCR and the 2-∆∆Ct method.  Gene expression in tissue is 
relative to the amount of mRNA of each gene in control tissue.  Gene expression in total cells 
and sorted cells from blood and milk is relative to the amount of mRNA of each gene in 
peripheral blood leukocytes during mastitis. ANOVA performed by SAS using the general 
linear model and multiple comparison tests were made using the Tukey adjustment. Error 
bars represent the SE.  *, ***Mean is different from other means, P < 0.05, P < 0.001, 
respectively.  
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CHAPTER 5. GENERAL DISCUSSION 
 
Discussion 
 
The studies in this dissertation provide the first evidence that 1α-OHase, the enzyme 
that converts 25(OH)D3 to 1,25(OH)2D3, is expressed by activated monocytes in cattle.  In 
monocytes, expression of 1α-OHase was induced by TLR ligands, indicating that it is 
induced upon innate recognition of pathogen-associated molecular patterns.  Further 
investigation with peripheral blood mononuclear cell (PBMC) cultures and mastitis indicated 
that in the bovine immune system 1α-OHase was predominantly expressed by monocytes and 
macrophages.  For example, 1α-OHase was only expressed by CD14+ cells (monocytes and 
macrophages) in M. bovis PPD-stimulated PBMCs, even though data indicated that 
lymphocytes also were activated.  Most important though, 1α-OHase expression was elevated 
the infected mammary glands during mastitis and 1α-OHase was predominantly expressed in 
CD14+ cells from the infected mammary glands.  Expression of 1α-OHase in CD14+ cells 
from the infected mammary gland gave the first evidence for any species that 1α-OHase is 
expressed at the site of a microbial infection. 
Production of 1,25(OH)2D3 by 1α-OHase in monocytes subsequently regulated the 
expression of several genes that have an important role in the immune system.  In monocytes, 
iNOS and RANTES expression increased with the concentration of 25(OH)D3.  Regulation 
of iNOS and RANTES by the concentration of 25(OH)D3 depended on synthesis of 
1,25(OH)2D3 from 25(OH)D3 by 1α-OHase in monocytes.  In M. bovis PPD-stimulated 
PBMC cultures, 25(OH)D3 up-regulated iNOS and RANTES expression and down-regulated 
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IFN-γ, IL-17A, and IL-17F expression.  There is no evidence that these genes are regulated 
by synthesis of 1,25(OH)2D3 in vivo, but 24-OHase, a gene that is only known to be 
regulated by 1,25(OH)2D3, was expressed much higher in infected mammary tissue than in 
healthy tissue. 
Expression of iNOS and RANTES in monocytes was up-regulated by 1,25(OH)2D3 
that was produced in monocytes, which is an example of intracrine regulation (Hewison, 
2010).  In contrast, IFN-γ, IL-17A, and IL-17F are generally known as T-cells cytokines 
(Dong, 2008; Hu and Ivashkiv, 2009); so, in M. bovis PPD-stimulated PBMCs, their 
expression was down-regulated in a paracrine fashion by 1,25(OH)2D3 that was presumably 
produced in monocytes.  RANTES also was originally discovered in T-cells (Schall et al., 
1988); so, 1,25(OH)2D3 from monocytes also may act in T-cells to up-regulate RANTES 
expression.  Altogether, 1,25(OH)2D3 produced in monocytes seems to 1) act in monocytes to 
up-regulate iNOS and RANTES expression and 2) act in T-cells to down-regulate IFN-γ, IL-
17A, and IL-17F expression and up-regulate RANTES expression (Fig. 1).  However, this 
dissertation does not give conclusive evidence that 1,25(OH)2D3 is directly down-regulating 
IFN-γ, IL-17A, and IL-17F expression.  In fact, macrophage-produced nitric oxide 
suppressed proliferation of mitogen-activated lymphocytes from rats (Fecho, 1994).  
Therefore, upregulation of nitric oxide production by synthesis of 1,25(OH)2D3 in monocytes 
may be causing apoptosis of surrounding T-cells, resulting in down-regulation of IFN-γ, IL-
17A, and IL-17F expression.  In light of that possibility, further experiments are needed to 
determine how vitamin D signaling is regulating T-cell associated immune responses.  
The genes that are regulated by 1,25(OH)2D3 in monocytes and PBMCs play an 
important role in the bovine immune system.  iNOS synthesizes nitric oxide which is 
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suggested to have several roles in the immune system (Bogdan, 2001).  In mice, killing of M. 
tuberculosis by macrophages depended on production of nitric oxide and iNOS knockout 
mice with tuberculosis develop more severe lesions (Thoma-Uszynski et al., 2001; Waters et 
al., 2004).  However, killing of M. tuberculosis in human macrophages does not depend on 
nitric oxide (Thoma-Uszynski et al., 2001) and 25(OH)D3 or 1,25(OH)2D3 did not enhance 
anti-bacterial activity of monocytes even though nitric oxide production was increased 
(Appendix A).  Besides bactericidal activity, nitric oxide is known to regulate blood flow and 
induce apoptosis in selected cells (Bogdan, 2001; Lacasse et al., 1996).  Production of nitric 
oxide in the mammary gland has a potential negative effect by inducing apoptosis in 
mammary epithelial cells (Zhao and Lacasse, 2008).  In any case, nitric oxide does have a 
significant role in host defense, so regulation of it by 1,25(OH)2D3 will likely impact immune 
function. 
RANTES is the other gene that was up-regulated by 1,25(OH)2D3 in monocytes and 
PBMCs.  RANTES is a chemokine that was originally discovered in T-cells (Levy, 2009), 
but has been shown to be expressed by macrophages and epithelial cells in cattle (Pareek et 
al., 2005; Widdison et al., 2008). The physiological impact of RANTES on immune function 
in cattle is not clear, but up-regulation RANTES by 1,25(OH)2D3 would likely facilitate 
attraction of other immune cells to the site of an infection. 
In PBMCs, 1,25(OH)2D3 down-regulated IFN-γ, IL-17A, and IL-17F.  All three of 
these cytokines are considered to be pro-inflammatory (Dong, 2008; Hu and Ivashkiv, 2009).  
IFN-γ primarily functions to activate macrophages and dendritic cells (Hu and Ivashkiv, 
2009), so down-regulation of IFN-γ expression by 1,25(OH)2D3 produced in activated 
macrophages may be a regulatory mechanism to limit over-activation of macrophages.  IL-
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17A and IL-17F act on fibroblasts and epithelial cells to induce cytokine production and 
neutrophil recruitment (Dong, 2008).  Recent studies in mouse models of auto immune 
disorders have provided evidence that IL-17A is involved in development of the disease 
(Joshi et al., 2009; Tang et al., 2009).  In cattle, IFN-γ and IL-17A have been associated with 
progression of tuberculosis and their expression is likely an important component of the 
immune response to mycobacterial infections (Vordermeier et al., 2002; Vordermeier et al., 
2009).  In general, 1,25(OH)2D3 is known to promote development of T-regulatory cells and 
immune tolerance (Cantorna et al., 2004); so, inhibition of these pro-inflammatory cytokines 
by 1,25(OH)2D3 may be involved in the promotion of a regulatory phenotype.    
There is clear evidence that immune responses in monocytes and PBMCs in vitro 
depend on the concentration of 25(OH)D3.  The current requirements for vitamin D in cattle 
target a circulating concentration of 20 to 50 ng/mL of 25(OH)D3 (NRC, 2001).  That range 
of 25(OH)D3 concentration is adequate for maintenance of calcium homeostasis in cattle 
(Horst et al., 2003).  However, discovery of intracrine and paracrine regulation of gene 
expression by 1,25(OH)2D3 indicates that vitamin D requirements for cattle need to be re-
examined.  Emerging evidence indicates that circulating 25(OH)D3 concentrations below 30 
ng/mL may be insufficient for proper immune function in people and an increasing number 
of studies have shown there is a correlation between disease prevalence and vitamin D status 
in people (Adams and Hewison, 2010).  Based on evidence from human studies, then, the 
current requirements for vitamin D in cattle may be insufficient for proper immune function.  
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Future Studies 
 
So far, the expression of several genes in monocytes and PBMCs have been shown to 
be regulated by 1,25(OH)2D3.  The physiological impact of vitamin D-mediated regulation of 
those genes, however, can only be presumed based on evidence from other species.  The 
unique nature of the bovine immune system, compared with the human and murine immune 
systems, indicates that additional investigation is needed to determine the physiological role 
of the 1,25(OH)2D3-regulated genes in the bovine immune system.  A better understanding of 
the function of the 1,25(OH)2D3-regulated genes will result in a better understanding of how 
vitamin D status impacts immune function in cattle. 
  In addition to vitamin D signaling in monocytes and PBMCs, preliminary studies 
have indicated that mammary epithelial cells express 1α-OHase and produce 1,25(OH)2D3 in 
response to unknown stimuli from monocytes (Appendix B).  In lactating cows, mammary 
epithelial cells have an important role in host defense in addition to their role in milk 
production (Rainard and Riollet, 2006). 1,25(OH)2D3 up-regulated iNOS and S100 A12 gene 
expression in mammary epithelial cells that were activated with LPS (Appendix B). In 
human and mouse mammary epithelial cell cultures, 1,25(OH)2D3 inhibits proliferation and 
has received much attention for the role it may have in prevention of breast cancer (Welsh, 
2007).  Therefore, investigating how 1α-OHase expression is triggered in bovine mammary 
epithelial cells has implications in bovine mastitis and milk production and in human health.    
Finally, there is substantial evidence to indicate that vitamin D is beneficial for 
immune function in cattle, but the optimal circulating concentration of 25(OH)D3 for proper 
immune function is not known.  Therefore, studies need to be completed to find if prevention 
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of infectious diseases or severity of disease is affected by vitamin D status.  In addition, there 
is not current information on the use of vitamin D supplements in cattle or the vitamin D 
status of herds in the United States or worldwide.  Efforts to keep track of vitamin D 
supplementation and vitamin D status in cattle are beneficial because of the potential impact 
it has on animal health.   
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Figures 
 
 
Figure 1.  Proposed mechanism for regulation of monocyte and T-cell responses by vitamin 
D signaling.  1,25D3, 1,25-dihydroxyvitamin D3; 25D3, 25-hydroxyvitamin D3; 1α-OHase, 
1α-hydroxylase; IL-17, interleukin-17; iNOS, inducible nitric oxide synthase; IFN-γ, 
interferon gamma; MHC, major histocombatibility complex; RANTES, regulated upon 
activation normally T-cell expressed and secreted; TCR, T-cell receptor; TLR, toll-like 
receptor; VDR, vitamin D receptor. 
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APPENDIX A: EFFECTS OF 25-HYDROXYVITAMIN D3 AND 1,25-
DIHYDROXYVITAMIN D3 ON MONOCYTE ANTI-BACTERIAL 
ACTIVITY 
 
 
 Summary 
 Nitric oxide production by activated monocytes was increased by 1,25(OH)2D3 or 
25(OH)D3 (Chapter 2, Figs. 2 and 4).  Nitric oxide is considered an antimicrobial molecule; 
so, we hypothesized that treatment of monocytes with 25(OH)D3 or 1,25(OH)2D3 would 
enhance their anti-bactecterial activity in vitro.  For killing of Streptococcus uberis, 
monocytes were pretreated with peptidoglycan with or without 1,25(OH)2D3 for 24 h then 
infected with S. uberis and allowed to kill for 1 h and 2 h. 1,25(OH)2D3 did not have an effect 
on the ability of monocytes to kill S. uberis (Fig. 1).  For Mycobacteria bovis BCG killing, 
monocytes were infected with M. bovis BCG and then cultured with or without 25(OH)D3 for 
24, 48, and 72 h.  25(OH)D3 did not affect killing of M. bovis BCG by monocytes (Fig. 2).  
Based on this evidence, 25(OH)D3 or 1,25(OH)2D3 do not enhance the anti-bacterial activity 
of monocytes. 
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Figure 1.  Monocytes from two cows were isolated by adherence to tissue culture flasks.  
The monocytes were transferred to 96-well plates and seeded at 5 X 105 cells/well.  
Monocytes were treated with 5 µg/mL peptidoglycan (PGN) and 0 (dashed line) or 4 (solid 
line) ng/mL 1,25(OH)2D3 in RPMI 1640 plus 10% FBS and 50 µg/mL gentamicin for 24 h. 
After 24 h, monocytes were washed and S. uberis was added at to the monocyte cultures at 
2:1 and 5:1 CFU S. uberis/monocyte in RPMI 1640 plus 10% FBS.  Monocyte were 
incubated with S. uberis for 30 min then washed 3X to remove extra-cellular S. uberis.  
Monocytes were cultured then lysed (10% PBS, 0.1% SDS) and log dilutions of lysate plated 
on blood agar plates or cultured for 1 or 2 more h in RPMI 1640 plus 10% FBS and 100 
µg/mL gentamicin (gentamicin was added to kill any remaining extra-cellular bacteria).  At 1 
h and 2h, monocytes were lysed and log dilutions of lysate was plated on blood agar plates.  
Each treatment was repeated 6X for each cow giving a total of 12 replicates.  Data are shown 
as the average number of colony forming units (CFU)X1000 of S. uberis in monocytes at 0, 
1, and 2 h after infection. 
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Figure 2.  Effects of 25(OH)D3 on monocyte M. bovis BCG killing.  Monocytes were 
isolated from peripheral blood by adherence to tissue culture flasks.  Monocytes were 
removed from the flasks and resuspended to 2.5X106 cells/mL in RPMI 1640 plus 10% FBS.  
M. bovis BCG was added to the monocyte suspension at a concentration of 106 M. bovis 
BCG/mL.  The monocyte/BCG suspension was placed in a 96-well plate.  After 3 h of 
incubation, monocytes were washed 2X to remove extra-cellular M. bovis BCG.  Fresh media 
(RPMI 1640 plus 10% FBS and 50 µg/mL gentamicin) was added along with 0 or 75 ng/mL 
25(OH)D3.  M. bovis BCG-infected monocytes were cultured for 0, 24, 48, or 72 h and then 
lysed with a 10% PBS, 0.1% SDS solution.  Log dilutions of the lysates were plated on 7H11 
agar plates and cultured for 3 weeks at 37°C. Data are shown as the average number of 
colony forming units (CFU) X 1000 of M. bovis BCG in monocytes of 3 replicates at 0, 24, 
48, and 72 h after infection.  
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APPENDIX B. 1α-HYDROXYLASE EXPRESSION AND EFFECTS OF 
1,25-DIHYDROXYVITAMIN D3 ON GENE EXPRESSION IN BOVINE 
MAMMARY EPITHELIAL CELLS 
 
A portion of these data appeared in the 2010 Animal Industry Report (Leaflet R2488) 
published by the Animal Science Department at Iowa State University 
 
Corwin D. Nelson, Timothy A. Reinhardt, Donald, C. Beitz, and John D. Lippolis 
 
Introduction 
 The vitamin D3 hormone is 1,25-dihydroxyvitamin D3 (1,25(OH)2D3).  The hormone 
can bind and activate the vitamin D receptor (VDR), a nuclear hormone receptor that 
regulates the expression of genes that contain a vitamin D response element in their 
promoter.  1,25(OH)2D3 is produced from 25-hydroxyvitamin D3 (25(OH)D3), the 
predominant circulating form of vitamin D3, by the enzyme 1α-hydroxylase (1α-OHase).  
We have recently shown that bovine monocytes express 1α-OHase in response to toll-like 
receptor (TLR) recognition of bacteria.  Production of 1,25(OH)2D3 by 1α-OHase in 
activated bovine monocytes increased production of nitric oxide and expression of the 
chemokine RANTES in monocytes.  We also have observed that 1α-OHase is expressed in 
inflamed mammary tissue during mastitis.  Human and mouse ammary epithelial cells have 
been shown to express 1α-OHase and produce 1,25(OH)2D3.  Production of 1,25(OH)2D3 up-
regulated 24-OHase gene expression in human mammary epithelial cells. The objectives of 
this experiment were to 1) determine the effects of 1,25(OH)2D3 and lipopolysaccharide 
(LPS) on iNOS, RANTES, and S100 calcium binding protein A12 (S100 A12) gene 
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expression in bovine mammary epithelial cells (MEC), and 2) determine if bovine MEC 
could express 1α-OHase. 
 
Materials and Methods 
 MEC were derived from mammary tissue biopsies of three Holstein cows in mid-
lactation.  The cells were cultured in RPMI 1640 plus 10% fetal bovine serum and mammary 
epithelial growth supplement (Invitrogen).  Prior to treatment, MEC were transferred to 96-
well tissue culture treated plates and cultured until they were confluent.   
 To test the effects of 1,25(OH)2D3 on gene expression in MEC, MEC cultures derived 
from 3 cows were treated with 0 or 1 µg/mL LPS along and 0, 0.1, 1 or 10 nM 1,25(OH)2D3 
for 16 h in duplicate.  
 To determine if 1α-OHase expression could be induced in MEC, MEC cultures 
derived from one cow were treated with 1 µg/mL LPS, 100ng/mL 25(OH)D3, supernatant 
from resting monocytes, and supernatant from LPS-activated monocytes in triplicate.  
Monocyte supernatants were prepared by isolating monocytes from peripheral blood and 
treating them with 0 or 100 ng/mL LPS for 24 h in the absence of 25(OH)D3.  Supernatants 
were collected, spun and filtered to remove monocytes.  
 After treatment, total RNA was isolated from MEC and reverse transcribed to cDNA.  
Quantitative real-time PCR using the 2-∆∆Ct method was used to measure relative abundance 
of 1α-OHase, 24-OHase, iNOS, RANTES and S100 A12.  Ribosomal protein S9 (RPS9) was 
used as the reference gene. 
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Results and Discussion 
 Treatment of MEC with 1,25(OH)2D3 caused an increase in 24-OHase gene 
expression in a dose dependent manner in both the presence and absence of LPS (Figure 1A).  
The 24-OHase enzyme adds a hydroxyl group to the 24 position of vitamin D metabolites, 
which inactivates 1,25(OH)2D3.  In bovine monocytes, induction of 24-OHase expression by 
1,25(OH)2D3 was repressed by LPS treatment.   
 In MEC treated with LPS, both iNOS and S100 A12 gene expression increased with 
1,25(OH)2D3 dose (Figure 1B and C).  In the absence of LPS, however, their was only a 
minimal response to 1,25(OH)2D3 for both genes.  Increased expression of iNOS resulted in 
increased nitric oxide production by MEC (not shown).  Nitric oxide may increase 
antimicrobial activity and blood flow in the mammary gland during mastitis, but it also may 
lead to MEC apoptosis.  The function of S100 A12 is not completely understood, but it has 
been shown to have chemotactic and antimicrobial properties. 
 RANTES expression in MEC did not increase with 1,25(OH)2D3 treatment (Figure 
1D).  Treatment with LPS, however, caused an increase in MEC RANTES expression.  In 
contrast, RANTES expression was up-regulated by 1,25(OH)2D3 treatment in LPS-stimulated 
bovine monocytes, but was not affected by LPS treatment alone. 
 Expression of 1α-OHase in MEC was up-regulated by treatment with supernatant 
from monocyte cultures activated with LPS (Fig. 2A).  Direct treatment of MEC cultures 
with LPS did not increase 1α-OHase gene expression.  Addition of 100 ng/mL of 25(OH)D3 
to MEC cultures up-regulated 24-OHase gene expression when 1α-OHase was expressed 
(Fig. 2b). 
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 In conclusion, 1,25(OH)2D3 acts in bovine MEC to enhance expression of iNOS and 
S100 A12 that is induced by TLR recognition of LPS.  Therefore, production of 1,25(OH)2D3 
by 1α-OHase in the mammary gland during mastitis may affect the host defense capabilities 
of MEC.  Expression of 1α-OHase is induced in MEC by a factor secreted by activated 
monocytes.  Further investigation is necessary to find what the factor form monocytes is that 
activates 1α-OHase gene expression in MEC.  
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Figure 1.  Mammary epithelial cell cultures were treated with 0 or 1 µg/mL LPS and 0 to 10 
nM 1,25-dihydroxyvitamin D3 for 16 hours.  The amount of 24-hydroxylase (24-OHase; A), 
inducible nitric oxide synthase (iNOS; B), S100 calcium binding protein A12 (S100 A12; C), 
and RANTES (D) mRNA in MEC was measured by quantitative PCR.  The expression of 
each gene was normalized to ribosomal protein S9 expression.  The fold increase is relative 
to the control treatment.  Results are the average gene expression in duplicate cultures 
derived from three cows.  Error bars represent standard error.  Means with different letters 
are different (P < 0.05). 
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Figure 2.  Mammary epithelial cells were cultured in 96-well plates and treated with 1 
µg/mL LPS, 100ng/mL 25(OH)D3, supernatant from resting monocytes (M. sup.), and 
supernatant from LPS-activated monocytes (LPS-stim. M. sup.) as indicated for 24 h.  
Supernatants from monocytes were prepared by culturing monocytes at 107 monocytes/mL 
with 0 or 100 ng/mL LPS for 24 h in the absence of 25(OH)D3, then supernatants were 
collected, spun, and filtered with a 0.2 micron filter to remove monocytes. 1α-Hydroxylase 
(1α-OHase) and 24-hydroxylase (24-OHase) mRNA in MEC was measured by quantitative 
PCR.  The expression of each gene was normalized to ribosomal protein S9 expression.  The 
fold increase is relative to the control treatment.  Results are the average gene expression of 3 
replicates.  Error bars represent standard error.  * P < 0.05. 
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